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Abstract 
Purpose: Ultrasound assessment of carotid disease is currently based on stenosis 
haemodynamic effects. The accuracy of direct stenosis measurement remains unclear, 
while research on atherosclerosis suggests identification of other plaque 
characteristics beyond size. The aim of the study is to investigate whether direct 
stenosis measurement and plaque ultrasound image analysis could potentially be used 
for more accurate diagnostic investigation. 
Method and material: Eighty-seven patients with cardiovascular disease had a 
carotid duplex ultrasound scan and velocity and B-mode measurements data were 
recorded for direct diameter measurement evaluation. Forty patients were scanned for 
quantitative plaque analysis and association of several parameters with symptoms was 
investigated. 
Results: For the degree of stenosis, ECST method indicated greater agreement among 
direct measurement methods with velocity criteria, however in cases of mild stenosis 
difference was reported. ECST method measurements showed considerably better 
agreement with MRA stenosis calculations compared with other methods. Intima-
media grey scale level was associated with plaque echogenicity but the correlation 
was not significant, however there was an association with blood cholesterol levels. 
Percentages of plaque area with grey scale value less than 35 and 40 showed good 
accuracy in identifying symptomatic patients. As far as fibrous cap is concerned, a 
thickness less than 300 μm was well correlated with symptomatic disease, however no 
association was noted for its echogenicity. 
Conclusion: ECST direct stenosis measurement method could potentially be used for 
better stenosis classification in cases with inconclusive haemodynamic estimations. 
Quantitative plaque analysis, such as fibrous cap thickness measurement and grey 
level analysis, shows promising results in association with symptomatic disease and 
particular plaque characteristics.  
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Chapter I 
Introduction 
1.1 Background 
Cardiovascular disease, a group of diseases related with the heart and blood vessels 
that includes ischaemic heart disease and stroke, is today the leading cause of death 
worldwide, being responsible for 30% of global deaths. 
Stroke specifically stands as a major social and healthcare burden worldwide, being at 
the same time a significant cause of disability. The overall economic cost of 
cerebrovascular disease in UK is estimated up to £5 billion per annum and is 
predicted to increase in the future. 
The majority of strokes are of ischaemic etiology, caused by a sudden decrease of 
blood flow in a part of the brain. This usually is a result of embolization of a cerebral 
artery, originating either from an atherosclerotic lesion at a more proximal artery, 
most commonly the carotid artery, or from the heart. Since atherosclerosis is a chronic 
progressive disease that can be identified, monitored and treated and its association 
with stroke is well documented, accurate investigation and early diagnosis of carotid 
atherosclerotic disease is of great importance for stroke prevention and management. 
Several imaging modalities are currently used for imaging the carotid arteries. 
However, it is duplex ultrasound that is predominantly used for routine assessment of 
carotid stenosis and treatment decisions, as well as patients follow up, depend 
predominantly on ultrasound findings. Its characteristics, being a quick, relatively 
cost-effective, noninvasive, patient-safe technique but also its potentials, since it 
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provides information about the anatomy and the functionality of the vessels explain its 
superiority over other modalities. 
Succeeding carotid angiography as the routine imaging technique for carotid disease 
assessment, duplex ultrasound investigation mainly focused on plaque size and degree 
of artery stenosis. Aiming to identify greater than 70% of stenosis, which 
angiographic studies in the „90s have set as a cut-off degree of stenosis for patient 
selection for endarterectomy, several velocity criteria were published from different 
centres, leading to confusion among vascular laboratories. The different approaches 
for stenosis calculation used in those angiographic studies, the American (NASCET) 
using the distal internal carotid artery diameter and the European (ECST) using the 
wall-to-wall diameter at the point of maximum constriction as reference, have led to 
confusion in the scientific community on what “degree of stenosis” represents and 
how velocity criteria should be interpreted. Meanwhile, direct diameter measurement 
of stenosis, a method that could help resolve the confusion, has not yet been included 
in recommendations for carotid imaging with the excuse of variability and 
overestimation of the stenosis. Despite being an indirect method for stenosis 
calculation, haemodynamic parameters are still preferred in current imaging protocols 
over direct stenosis measurement. Whether the latter could and should be used along 
with, or instead of, velocity measurements, remains unclear. 
Furthermore, scientific interest in atherosclerosis has also focused on the 
identification of characteristics of the vulnerable plaque, i.e. the plaque which is prone 
to rupture and lead to symptomatic disease. Thereafter, the need for an additional, 
beyond the degree of stenosis, approach of carotid plaque has become apparent. Over 
the last decade effort has been made in examining the possible association of 
ultrasound plaque image characteristics with compositional and morphologic plaque 
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characteristics with promising results. Despite the fact that several studies have 
associated several ultrasound image characteristics with histological characteristics of 
carotid plaque and clinical symptoms, plaque echogenicity being the most 
representative example, qualitative and quantitative characterization of the plaque has 
not been yet standardized and hence not included in routine ultrasound imaging 
practice. Meanwhile, newer characteristics of vulnerable atherosclerotic plaque, such 
as inflammation, neovascularization and fibrous cap thickness, are being investigated 
and there is ongoing research on methods for identifying and quantifying those 
characteristics for a better assessment and treatment of carotid atherosclerotic disease. 
1.2 Hypothesis 
This study addresses various issues on duplex ultrasound investigation of carotid 
atherosclerotic disease aiming to recommend potential changes in the routine practice, 
combining previously suggested methods with modern knowledge on atherosclerosis. 
The main hypothesis of the study is that a holistic assessment of carotid plaque which 
would combine haemodynamic parameters with direct stenosis measurements and 
would include quantitative details of the plaque derived from image texture analysis 
and additional measurements could potentially be an accurate and helpful diagnostic 
tool for identifying the high-risk patient as well as monitor the disease progress. 
More specifically: 
 Direct stenosis measurement methods will be compared with established 
velocity criteria for stenosis calculation as well as stenosis measurements 
using MRA for selection of the most appropriate and accurate for ultrasound 
use. 
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 Accuracy of direct stenosis measurement methods will be examined in relation 
with current velocity criteria in determining degree of stenosis and identifying 
severe stenosis. 
 Association of plaque image characteristics such as echogenicity, 
heterogeneity and plaque image texture analysis results with symptomatic 
disease will be investigated. 
 Association of plaque fibrous cap and intima-media ultrasound image analysis 
with symptomatic disease will be investigated 
A review of literature on current assessment of carotid atherosclerotic disease and 
new developments on identifying the vulnerable carotid plaque using ultrasound and 
other imaging modalities is followed by methods and results of each study addressing 
the above issues, summarizing with a discussion on study‟s findings and 
recommendations for further research. 
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Chapter II 
Carotid atherosclerotic disease 
2.1 Introduction 
Cardiovascular disease, nicknamed as “the disease of civilization”, consists of a group 
of pathologic disorders of heart and the blood vessels. The class includes coronary 
heart disease (acute myocardial infarction, acute coronary syndromes, angina 
pectoris), cerebrovascular disease (stroke, transient ischaemic attack), peripheral 
artery disease (e.g. lower limb artery stenosis), rheumatic fever/rheumatic heart 
disease, hypertensive disease, congenital heart disease, heart failure, 
cardiomyopathies, heart valve diseases, aortic aneurysms and dissection, arrhythmias, 
diseases of pulmonary circulation (e.g. pulmonary embolism), disease of veins, 
lymphatics and lymph nodes etc, however the term usually refers to diseases 
pathophysiologically related to atherosclerosis. Despite the great incidence and 
prevalence of cardiovascular disease, particularly in countries of the so-called 
Western civilization, most of these diseases can be accurately diagnosed and 
efficiently managed due to the evolution of medical equipment and drug industry. 
2.2 Epidemiology 
Cardiovascular diseases 
Cardiovascular diseases are the leading cause of mortality in developed countries and 
a rising tendency in developing countries. According to World Health Organization, 
in 2005 17.5 million people died of cardiovascular disease worldwide, representing 
30% of all global deaths. Among all the cardiovascular disorders, coronary artery 
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disease and cerebrovascular disease were responsible for most of the deaths, causing 
7.6 million and 5.7 million deaths respectively on 2005. Over 80% of deaths due to 
cardiovascular diseases take place in low- and middle-income countries. It is 
estimated that by 2030 almost 23.6 million people will die from cardiovascular 
diseases, mainly from heart disorders and stroke, which are projected to remain the 
leading causes of death worldwide. 
The current American Heart Association update on heart disease and stroke in United 
States, issued annually, estimates that more than 1 per 3 American adults have one or 
more types of cardiovascular disease; Over 16 million Americans suffer from 
coronary heart disease and nearly approximately 7 million from stroke. Mortality data 
are also alarming; on average, in U.S., 1 death every 39 seconds is a result of 
cardiovascular disease, which was the underlying cause of 813,804 deaths (of total 
2,423,712) in U.S. in 2007 (Roger et al, 2011) (Fig 2.1). 
 
Fig 2.1, Percentage breakdown of deaths per underlying cause in U.S.A. in 2007 (Roger et 
al. 2011) 
It is however noteworthy that the death rates (i.e. number of deaths per 100,000 
population) due to cardiovascular disease have declined by 27.8% from 1997 to 2007, 
33%
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a decrease that, as far as coronary artery disease is concerned, is attributed to 
increased use of evidence-based medical therapies and changes in modifiable risk 
factors (Ford et al, 2007). 
Similarly, the rates in United Kingdom in 2007 indicate that cardiovascular disease 
was the leading cause of death, responsible for approximately 33% of deaths in men 
and women (Fig 2.2, Fig 2.3). 
 
 
Fig 2.2, Percentage breakdown of deaths per underlying cause in men and women across UK 
in 2007(Scarborough P et al, 2009)  
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Fig 2.3, Death rates (number of deaths per 100,000 population) for coronary heart disease, 
stroke and other cardiovascular disease for men and women aged 37-74 years old in UK in 
2007 (Roger et al, 2011) 
 
Stroke 
Stroke  is a major social and healthcare burden worldwide. World Health Organization 
classifies stroke as the third most common single cause of death, exceeded only by 
coronary heart disease and cancer (Fig. 2.4). Among the cardiovascular diseases, 
stroke is the second cause of death, below coronary heart disease (Fig 2.5). Annually 
15 million people worldwide suffer a stroke. Of these, 5.5 million die (3 million 
women and 2.5 million men) and another 5 million are left permanently disabled. In 
the UK approximately 50,000 people die every year of stroke, while in the U.S. every 
40 seconds someone has a stroke and every four minutes someone dies of a stroke 
(Miniño et al, 2009; Bhatnagar et al, 2010). 
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Fig 2.4, Number (in millions) and percentage of deaths worldwide from stroke and other 
leading causes in 2002 (Mackay & Mensah, 2004) 
In UK, stroke is one of the largest health burdens, causing in 2007 around 53,000 
deaths (approximately 9% of all deaths, Fig 2.2) and more than 175,000 consultant 
visits in National Health Service hospitals, whilst it is estimated that each year 
111,000 new strokes occur. It is one of the main causes of serious long-term 
disability, causing 3% of the world‟s disability burden (Warlow et al, 2003) and being 
the biggest single cause of major disability in UK (Mackay & Mensah, 2004). 
Since 1990s the number of inpatient cases of stroke in England has increased by 
approximately 25% and over 21,000 surgical procedures in England are stroke-
related. Its economic consequences are alarming, as the economic cost for the UK 
health and social care system in 2006/07 was estimated over £2.5 billion for stroke 
management and £370 million for transient ischaemic attack, adding up to a total cost 
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of £5 billion, including production losses due to mortality and morbidity (Bhatnagar 
et al, 2010). The burden of stroke is predicted to increase over the years ahead as a 
consequence of UK‟s ageing population. Therefore, prevention programs that are 
aimed at the reduction of risk factors as well as efficient and rapid diagnosis of stroke 
are crucial. 
 
Fig 2.5, Percentage breakdown of deaths in U.S. in 2007 due to cardiovascular disease 
(Roger et al, 2011) 
2.3 Pathological types of stroke 
Stroke is the clinical syndrome of rapid onset of focal (or global, as in subarachnoid 
haemorrhage) cerebral deficit, lasting more than 24 hours or leading to death, with no 
apparent cause other than a vascular one. If symptoms are temporary and patient 
recovers in less than 24 hours, the clinical syndrome is called transient ischaemic 
attack (TIA). There are three pathological types of stroke (Fig. 2.6): 
 Ischaemic stroke, caused by vascular infarction (80%) 
 Primary intracerebral haemorrhage (15%) 
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 Other causes, like subarachnoid haemorrhage, tumor etc (5%) 
The cause of approximately 50% of strokes is the atherothrombotic disease of the 
extracranial - or less commonly large intracranial – arteries. About 25% of strokes are 
caused by occlusion of one of the small perforating cerebral arteries and they are 
called lacunar infarcts, whether 20% are caused by emboli form the heart, usually 
because of atrial fibrillation. The remainders are due to rarer causes, like arterial 
dissection, vasculitis, or remain cryptogenic despite thorough investigation (Warlow 
et al, 2003).  
 
Fig 2.6, Frequency of main types and subtypes of stroke (Warlow et al, 2003) 
2.4 Anatomy of cerebrovascular system 
The brain receives 15% of the cardiac output and is supplied by four vessels, the right 
and left carotid and vertebral arteries. On the left side the common carotid artery 
(CCA) and the subclavian artery arise from the aortic arch, whereas on the right side 
the branchiocephalic artery, also called the innominate artery, arises from the aorta 
and then divides into the right subclavian artery and right common carotid artery. 
The CCA divides then into the internal (ICA) and external (ECA) carotid arteries, the 
level of bifurcation being highly variable (Fig. 2.7). At that level, the CCA widens to 
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form the carotid bulb. There are several variations of the carotid bulb morphology, as 
it may involve the proximal ICA instead of the distal CCA, or may involve both ICA 
and ECA. In 90% of cases the ICA lays posterolateral or lateral to the ECA and lacks 
of extracranial branches. By contrast, the ECA branches into the superior thyroid, 
ascending pharyngeal, lingual, facial, occipital, posterior auricular, maxillary and 
superficial temporal arteries. In the skull, the ICA follows a curved path, known as the 
carotid siphon, and finally divides into the middle cerebral artery and the anterior 
cerebral artery. The intracranial segment of ICA gives branches, the most important of 
which is the ophthalmic artery, whose terminal branches, the supratrochlear and 
supraorbital arteries connect with the terminal branches of ECA to form a normal 
collateralization system. The middle and anterior cerebral artery, along with the 
posterior cerebral artery, which arises from the basilar artery, form the Circle of 
Willis (Fig. 2.8). The Circle of Willis provides collateralization between the anterior, 
posterior, right and left brain circulation. 
 
Fig 2.7, Anatomy of neck arteries (adapted from Gray’s Anatomy, edited by T.P.Pick and 
R.Howden) 
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The vertebral arteries are the first branches of the subclavian arteries. They pass 
upwards through the transverse processes of the spine and join at the base of the skull 
to form the basilar artery, which then divides to right and left posterior cerebral 
arteries. 
 
Fig 2.8, Circle of Willis (Thrush et al., 2004) 
2.5 Atherosclerosis 
Atherosclerosis is the most frequent underlying cause of coronary, carotid and 
peripheral arterial disease and is responsible for a large number of deaths each year 
worldwide. It is a chronic immunoinflammatory fibroproliferative disease of large and 
medium-sized arteries. It results in the formation of atherosclerotic lesions and 
plaques which cause stenoses in the arteries and are potentially prone to rupture. 
2.5.1 Formation of atherosclerotic plaque 
Although the exact mechanisms of the pathogenesis of atherosclerosis are still 
uncertain, the “response-to-injury” theory is most widely accepted. According to that 
theory, the first stage of atherosclerosis is the injury of the endothelium, the inner 
layer of artery wall, caused by oxidized low-density lipoprotein cholesterol (LDL), 
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turbulent flow, infectious agents, toxins including by-products of cigarettes smoking, 
hyperglycemia etc. Sites of disturbed laminar flow in the vascular network, like 
arterial branch points and bifurcations, are particularly prone to endothelial injury 
because of wall shear stress. 
In lesion-prone areas plasma molecules and lipoproteins extravasate through the leaky 
and dysfunctional endothelium into the subendothelial space (Fig. 2.9). There, 
through still unclear mechanisms which include oxidation, lipoproteins are retained 
and modified and become cytotoxic, proinflammatory, chemotaxic and 
proatherogenic. Lipid material is then ingested by macrophages which are recruited as 
an immunologic response to the atherogenesis forming foam cells, so named because 
of their foamy microscopic appearance. These early and generally asymptomatic 
lesions that contain only endothelial cells, macrophages and few T-cells are called 
fatty streaks and can be observed in the arteries of most individuals by the age of 20s. 
 
Fig 2.9, Formation of the atherosclerotic plaque 
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The subendothelial foam cells release atherogenic oxidized LDL and reactive oxygen 
species, further impairing the function of endothelial cells, which apart from forming 
a barrier between blood flow and underlying tissue, they also produce substances that 
regulating the vascular tone and arterial health. Nitric oxide, the main endothelial-
derived substance, is an important antiatherogenic factor, since it inhibits platelet 
aggregation, monocyte adhesion and abnormal smooth muscle cell proliferation. 
As the disease progresses, smooth muscle cells which are responsible for healing and 
repair after arterial injury, migrate from the muscular layer to the subendothelial layer 
and become transformed into fibroblasts. These form a collagenous (fibrous) matrix 
within the plaque and also a fibrous cap on the luminal side of the plaque, below the 
intima layer. As a result, lumen and blood flow get reduced causing ischaemia. 
Nevertheless, smooth muscle cells and collagen-rich matrix confer stability to 
plaques, protecting them against much more ominous consequences like plaque 
rupture and thrombosis (Falk, 2006). 
2.5.2 Plaque rupture and thrombosis 
As atherosclerosis progresses, endothelial cells, macrophages and smooth muscle 
cells die by apoptosis or necrosis. Disintegration of foam cells and loss of smooth 
muscle cells may have detrimental consequences, leading to the formation of a 
destabilizing lipid-rich core and a fragile and rupture-prone fibrous cap. A lesion with 
these characteristics is called atheroma and despite the fact that it may not 
significantly increase in size, it is prone to rupture leading to formation of thrombus 
and embolization. Apoptosis also contributes to the thrombogenicity of the lipid-rich 
core. Focal calcification and neovascularization as well as intraplaque haemorrhage 
occurs and increases with age, being more prominent in advanced atherosclerosis. 
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Inflammation plays a significant role in plaque rupture, as macrophages release lytic 
enzymes which degrade the fibrous cap. Plaque rupture is also facilitated by 
vasospasm and increased or oscillating shear stress. Under these circumstances plaque 
rupture may occur, exposing the thrombogenic lipid-rich atheromatous core to the 
flowing blood. This can be followed by variable amount of haemorrhage into the 
plaque and nonfatal or fatal thrombosis of the vessel or embolization. 
2.5.3 Risk factors 
Since the Framingham Heart Study in 1960s, there is continuous research in 
atherosclerosis in an effort to identify cardiovascular risk factors and ways they can 
be modified. The impact of traditional risk factors such as age, sex, hypertension and 
smoking, has long been demonstrated beyond any doubt. However, new risk factors 
have emerged, like elevated levels of homocysteine, CRP and triglycerides. The risk 
factors can be divided into modifiable and non modifiable. 
Non modifiable risk factors 
Sex 
Men are shown to be more prone in atherosclerosis than women. One stated reason is 
the protective role of estrogens in pre-menopausal women. Between 35 and 55 men 
are five times more prone in atherosclerosis than women. 
Age 
Age has a dominant influence in atherosclerosis and is traditionally considered as a 
risk factor for atherosclerosis, probably due to atrophic and degenerative changes to 
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the blood vessel wall. Early lesions appear in childhood and disease rises with each 
decade. 
Family history of premature cardiovascular disease 
Family history of coronary heart disease, stroke, TIA or peripheral arterial disease is a 
significant independent predisposing risk factor for atherosclerosis. It is noteworthy 
that the relative risk is greater in case of disease of mother compared to father. 
Furthermore derangements in lipoprotein metabolism, like familial 
hypercholesterolaemia, are strongly correlated with cardiovascular diseases. 
Modifiable risk factors 
Cholesterol 
Hypercholesterolaemia, i.e. high levels of total cholesterol, low-density lipoprotein 
(LDL) cholesterol and low levels of high-density lipoprotein (HDL) cholesterol, is a 
well established independent risk factor for atherosclerosis and cardiovascular 
diseases. Low-density lipoproteins can enter the subintimal area of the vasculature 
and play a significant role in the formation of atherosclerotic plaque. An LDL/HDL 
ratio over 5 has been correlated with increase probability for cardiovascular disease. 
Lowering serum cholesterol levels has been proved to significantly reduce the risk of 
subsequent coronary heart disease events and overall mortality. 
According to British Heart Foundation statistics, in England in 2006, 57% men and 
61% women had blood cholesterol levels above the target for primary and secondary 
prevention (5.0 mmol/l) (Scarborough P et al, 2009). Centers of Disease Control and 
Prevention in US suggest that a 10% population-wide decrease in total cholesterol 
levels could decrease the cardiovascular disease events by 30% (Roger et al, 2011). 
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Smoking 
Cigarette habituation is a major risk factor for atherosclerosis and is associated with 
an increased relative risk of dying from cardiovascular disease. The mechanisms, still 
not completely clear, include platelets activation, increase of blood viscosity, increase 
of oxidized LDL and decrease of HDL, resulting in endothelial dysfunction and a 
relatively hypercoagulable state. The adverse effects of smoking on vascular wall 
structure have been evaluated by autopsy studies (Solberg & Strong, 1983). A dose-
response relationship between the number of cigarettes smoked and the risk for 
ischaemic stroke has been reported, and the risk is significantly reduced within two 
years after smoking cessation (Iso, 2011). 
Hypertension 
Hypertension is a well established risk factor for atherosclerosis and cardiovascular 
diseases. It is associated with morphologic alterations of the arterial intima that 
increase its permeability and functional alterations of the endothelium, similar to the 
changes observed in hypercholesterolaemia and established atherosclerosis. 
Hypertension has been shown in both epidemiological and experimental studies to 
accelerate atherosclerotic vascular disease and increase the incidence of clinical 
complications. Studies have shown that patients with well controlled blood pressure 
(<120/80 mm Hg) have approximately half the lifetime risk for stroke compared to 
patients with hypertension (Mancia, 2010). 
Metabolic syndrome 
The metabolic syndrome encompasses a range of cardiovascular risk factors and is 
diagnosed when ≥3 of the following risk factors are present: elevated triglycerides 
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(≥150 mg/dL), low HDL cholesterol (<40 mg/dL in men or <50 mg/dL in women), 
impaired fasting glucose (≥100 mg/dL), high blood pressure (≥130 mm Hg systolic or 
≥85 mm Hg diastolic) and increased waist circumference (≥102 cm in men or ≥88 cm 
in women). It has been established that it increases a patient‟s risk factor for 
atherosclerosis, carotid atherosclerosis and coronary artery disease at any level of 
LDL cholesterol (Bonora et al., 2003). A recent meta-analysis of 37 prospective 
studies concluded that metabolic syndrome had at a relative risk for cardiovascular 
disease of 1.78, showing higher association in women (2.63) and independence from 
other traditional risk factors (Gami et al, 2007). 
Diabetes mellitus 
Diabetes mellitus is an important risk factor for atherosclerosis and dyslipidaemia and 
is commonly associated with hypertension, abnormalities of coagulation, platelet 
adhesion and aggregation, increased oxidative stress and functional and anatomical 
abnormalities of the endothelium. The Framingham Study, over 30 years ago, 
established diabetes as an independent risk factor for cardiovascular disease and today 
diabetes is considered as a coronary heart disease risk equivalent, as diabetes confers 
a 10-year coronary heart disease risk equal to that of persons with existing coronary 
heart disease (Fruchart et al, 2004). Diabetes has been found to increase stroke 
incidence at all ages and generally patients with diabetes who suffer an ischaemic 
stroke are more likely to also suffer from hypertension, coronary heart disease and 
hypercholesterolaemia (Roger et al, 2011). 
Lipoprotein (a) 
Lipoprotein(a) [Lp(a)] is the combination of a LDL-similar lipoprotein, 
apolipoprotein B100, with a carbohydrate-rich hydrophilic protein called 
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apolipoprotein(a). Despite the fact that the pathophysiological mechanism remains 
obscure, its dual structure suggests its involvement in the process of both 
atherogenesis and thrombosis. In vitro studies have shown association of Lp(a) with 
increased expression of adhesion molecules and increased production of monocyte 
chemotactic protein and interleukin-8 (Kamstrup, 2010). Elevated levels of Lp(a),  
particularly plasma levels exceeding 20 to 30 mg dL
-1
, have been causally associated 
with increased risk for developing cardiovascular disease. However, no randomized 
clinical trial has shown that lowering Lp(a) levels decreases cardiovascular diseases 
risk (Fruchart et al, 2004). 
Triglycerides 
Although it had been a matter of debate, studies have shown that high triglyceride 
levels should be considered an independent risk factor for cardiovascular disease 
independent of LDL and HDL cholesterol levels, diabetes or hypertension (Hokanson 
& Austin, 1996; Yarnell et al, 2001). 
Homocysteine 
Homocysteine is formed during demethylation of methionine. Impaired homocysteine 
metabolism has been implicated as a factor in atherosclerosis, cerebrovascular disease 
and peripheral vascular disease. Causes of hyperhomocysteinaemia include genetic 
causes (i.e. heterozygous cystathionine-β-synthase deficiency), vitamin deficiency 
(folic acid, B12 vitamin, B6 vitamin) or impaired renal function. The exact 
mechanism by which high homocysteine levels may be translated into increased risk 
for atherosclerosis remains speculative, but endothelial dysfunction through oxidation 
of LDL, production of free radicals and impairment of nitric oxide metabolism, 
enhancement of platelet aggregation and vascular smooth muscle proliferation are 
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considered (Fruchart et al, 2004; Kullo & Ballantyne, 2005). Recent prospective 
studies have established the causal association and the independency of increased 
homocysteine levels as a cardiovascular disease risk factor, indicating that increase in 
homocysteine level by 5 μmol/l increases the risk by approximately 20% (Humphrey 
et al, 2008). 
Fibrinogen 
Fibrinogen is a circulating glycoprotein which acts as the final step in the coagulation 
response to vascular and tissue injury. Apart from that role, it regulates cell adhesion, 
chemotaxis and proliferation, leads to vasoconstriction at sites of vessel wall injury, 
stimulates platelet aggregation and determines blood viscosity. Recent studies and 
meta-analyses support an independent association between elevated levels of 
fibrinogen and cardiovascular morbidity and mortality as well as between fibrinogen, 
ischaemic stroke and peripheral vascular disease (Tanne et al, 2001).  
High-sensitivity C-reactive protein 
C-reactive protein (CRP) is a circulating acute-phase reactant increased during the 
inflammatory response to tissue injury or infection. Despite being a very nonspecific 
marker, high-sensitivity CRP (hs-CRP) levels have been found to have predictive 
value for coronary and peripheral atherosclerosis. Hs-CRP constitutes a strong and 
independent predictor of advanced carotid plaques in dyslipidaemic subjects and 
early-onset carotid atherosclerosis is associated with elevated serum levels of 
inflammatory markers (Blackburn R et al., 2001). CRP has been suggested to play a 
role in the pathogenesis of atherosclerosis, as it could promote low-density lipoprotein 
cholesterol uptake by macrophages, amplify the inflammatory response and promote 
endothelial activation (Mosca, 2002). However, the causal association with 
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cardiovascular disease has not proved yet and recent studies tend to reject the direct 
role scenario, suggesting its use as a marker rather than a risk factor (Genest, 2010; 
Elkind, 2010). Recent trials (CARE trial, AFCAPS/TexCAPS trial) have reported 
greater impact in lowering cardiovascular risk with statin treatment in patients with 
high hs-CRP levels comparing to low hs-CRP levels. These results suggest using hs-
CRP as a criterion for selection of patients for statin treatment even in the absence of 
dyslipidaemia (Ridker et al, 2008; Mora & Ridker, 2006). 
Overweight and obesity 
Overweight and obesity have long been considered as independent risk factor for 
cardiovascular disease. The relative risk for cardiovascular disease is increased by 
21% and 20% for overweight men and women respectively and by 46% and 64% for 
obese men and women respectively (Wilson et al, 2002). In England from 1994 to 
2006 the prevalence of obesity has increased by 50% for men and women and it is 
predicted that by 2050 60% of UK adult population would be obese (Scarborough P et 
al, 2009). A recent study conducted in U.S. showed that although lifestyle changes 
like smoking cessation and modern treatments of cholesterol and blood pressure have 
resulted in gaining 2,770,500 life-years, obesity and diabetes have reduced this gain 
by 715,000 life-years (Capewell et al, 2009). 
Sedentary lifestyle 
Studies commonly report an inverse association between physical activity and 
cardiovascular disease risk. Perspective studies have reported decrease of relative risk 
for cardiovascular events and cardiovascular mortality with physical activity, and 
although results about dose-response relationship are mixed when risk is adjusted for 
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other risk factors, most studies agree that vigorous physical activity can significantly 
reduce cardiovascular relative risk (Carnethon, 2009; Yu et al, 2003) 
Other risk factors 
Other risk factors, such as hypercoagulable states, race, alcohol intake, psychological 
factors (stress, depression, aggressive behaviour), microalbuminuria, uric acid etc 
have been correlated with pathogenesis and progression of atherosclerosis. In some 
cases the exact pathophysiological mechanisms are still unclear. 
2.5.4 Clinical features of atherosclerotic disease 
The formation of atherosclerotic plaque can be the cause of different cardiovascular 
diseases, with similar pathophysiologic mechanisms but different symptomatology, 
diagnostic procedures and treatment, depending on which vessel the plaque is formed 
in. 
Coronary heart disease 
In coronary heart disease or ischaemic heart disease the atherosclerotic lesion is 
formed in one or more coronary arteries of the heart (Fig. 2.10). It is clinically 
manifested by angina pectoris, precordial chest pain usually precipitated by stress or 
exertion, relieved at rest or by nitrates, and in late stages by acute coronary 
syndromes, which include unstable angina and acute myocardial infarction. Coronary 
heart disease is the leading cause of death worldwide (Fig 2.4). 
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Fig 2.10, Coronary artery disease in drawing (left) and in coronary angiogram (right) 
Cerebrovascular disease 
The presence of atherosclerotic plaque in carotid arteries, usually in proximal internal 
carotid artery or in the carotid bulb, which may cause either haemodynamic changes 
in blood flow or, more often, thromboembolism in more distal branches, is stated as 
carotid artery disease. Its clinical manifestations include contralateral weakness or 
sensory loss, expressive aphasia or amaurosis fugax (transient partial or complete loss 
of vision in the ipsilateral eye) and it is considered as a major cause of transient 
ischaemic attack and ischaemic stroke. Furthermore, formation of atherosclerotic 
plaque in vertebral artery can cause vertebrobasilar transient ischaemic attack, which 
is characterized by brainstem and cerebral symptoms including dysarthria, diplopia, 
vertigo, ataxia and hemiparesis or quadriparesis. 
Peripheral vascular disease 
Atherosclerosis in limb arteries can cause peripheral vascular disease, also called 
peripheral arterial occlusive disease. It leads to insufficient tissue perfusion that may 
acutely be compounded by either emboli or thrombi. Lower limb arterial occlusive 
disease is more common than upper limb disease. Its main symptom is intermittent 
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claudication, which is defined as pain or discomfort in limb muscle which occurs after 
a reproducible amount of exercise and is relieved within a few minutes of rest. In 
more severe conditions it can cause critical limb ischaemia, that manifests as rest pain 
which requires analgesia and/or ulceration or gangrene, which if not properly 
managed can eventually lead to loss of limb or even life. 
Renal artery stenosis 
Atherosclerotic plaque is the cause of 80-90% of patients with renal artery stenosis 
(Fig. 2.11). It clinically manifests as renovascular hypertension, which accounts for 
about 5% of all cases of hypertension, and ischaemic nephropathy. 
 
Fig 2.11, Angiogram of renal artery stenosis 
2.6 Carotid atherosclerotic disease 
The formation of atherosclerotic plaque in the carotid artery, usually at the site of the 
carotid bifurcation, proximal ICA or the carotid bulb, is called carotid atherosclerotic 
disease, and is a major cause of ischaemic stroke. 
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2.6.1 Symptoms and indications for investigation 
Carotid atherosclerotic disease has been associated with contralateral hemi-
paresthesia, dysphasia, ipsilateral monocular blindness, residual blurriness, syncope, 
confusion and seizure. Major indications for imaging investigation include carotid 
bruits, amaurosis fugax, hemispheric transient ischaemic attacks and recent stroke. A 
large number of patients are diagnosed during screening for carotid stenosis, usually 
prior to coronary artery bypass grafting operation for coronary artery disease 
treatment, since there is significant risk of stroke postoperative in patients with severe 
coronary heart disease. It is common practice in many cardiothoracic centres to 
combine carotid endarterectomy with coronary artery bypass grafting in those 
patients. 
2.6.2 Imaging investigation 
The degree of carotid artery stenosis is of great importance in the diagnosis, prognosis 
and treatment of the carotid atherosclerotic disease and prevention of stroke. Major 
trials have been conducted showing higher risk of stroke in greater degrees of 
constriction, defining thresholds for the beneficial results of carotid endarterectomy to 
patients with symptomatic carotid stenosis (North American Symptomatic Carotid 
Endarterectomy Trial. Methods, patient characteristics, and progress, 1991, MRC 
European Carotid Surgery Trial: interim results for symptomatic patients with severe 
(70-99%) or with mild (0-29%) carotid stenosis. European Carotid Surgery Trialists‟ 
Collaborative Group, 1991) and also asymptomatic stenosis (Endarterectomy for 
asymptomatic carotid artery stenosis. Executive Committee for the Asymptomatic 
Carotid Atherosclerosis Study, 1995). In addition to degree of stenosis, other carotid 
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plaque characteristics, such as composition and inflammation, are now considered as 
plaque vulnerability factors and research has focused on use of imaging modalities to 
identify and quantify them. Determination of severity of carotid disease is crucial for 
the patient management and several imaging modalities are being used, each one with 
its advantages and limitations. 
Digital subtraction angiography 
Digital subtraction angiography (DSA) used to be the gold standard for the estimation 
of carotid artery stenosis. The two major endarterectomy trials (North American 
Symptomatic Carotid Endarterectomy Trial. Methods, patient characteristics, and 
progress, 1991, MRC European Carotid Surgery Trial: interim results for 
symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. 
European Carotid Surgery Trialists‟ Collaborative Group, 1991) for the determination 
of the threshold percentage of carotid stenosis above which endarterectomy is the 
favourable treatment, were undertaken during the 1980s up to mid 1990s and used 
DSA as the gold standard, establishing purely angiographic criteria. Since then, 
however, newer techniques have become widely available, replacing DSA in the 
routine practice. DSA has many limitations and it is now rarely used. It is an invasive 
technique with a relatively high risk of morbidity and mortality, ranging from 1% to 
4% in patients with atherosclerosis (Willinsky et al, 2003). A risk for iatrogenic 
stroke of 1.2% has also been reported (Mintz & Hobson, 2000). Even patients without 
apparent neurological complications have been found to develop minor asymptomatic 
infarctions resulting from microembolism after DSA (Bendszus et al, 1999). It is an 
expensive procedure, usually performed in hospital, and the use of contrast agent can 
potentially cause allergic reaction to patient. As far as its diagnostic accuracy is 
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concerned, DSA can in many cases underestimate the stenosis. The fact that DSA can 
image only the lumen of the vessel and not the vessel wall, being unable to provide 
arterial cross-sectional views, leads to different assumptions about the true diameter 
of the vessel and the diameter reduction. For these reasons DSA has gradually been 
replaced by other non-invasive, less risky and more advanced modalities. 
Duplex ultrasound 
Duplex ultrasound (DUS) has replaced angiography in most diagnostic circumstances 
and is today the first diagnostic tall in doctor‟s quiver. It is a non-invasive imaging 
modality which uses the physical principles of ultrasound waves and the Doppler 
phenomenon for the imaging of subcutaneous tissues and organs. It is safe for the 
patients and the operator, since it does not expose them to harmful radiation. DUS is a 
real time imaging modality which allows the visualization of both lumen and wall of 
the vessel, without the necessity of contrast agent administration. On the other hand, it 
can only be used for imaging of the extracranial parts of CCA, ICA and ECA, as 
ultrasound beam cannot penetrate the skull. The operator can insonate the artery in 
any dimension from any view just by orientating the transducer and can take images 
of the artery in long and short axis, visualizing the actual vessel and the lumen area. 
This is a major advantage of the ultrasound compared to other angiographic imaging 
modalities, either conventional or newer. 
DUS can also investigate the morphology of the plaque and provide details about its 
composition, which has turned out being of great importance for the prognosis of the 
disease. It is well established that lipid rich ulcerated plaques are more prone to 
rupture and haemorrhage than calcified fibrous plaques. A lot of studies looking into 
plaque characterization with DUS have concluded that it can efficiently differentiate 
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these two categories. In addition, DUS can provide details about the characteristics of 
the blood flow, such as peak systolic velocity and flow volume, which gives 
information about the vessel at the insonation point, but also proximally and distally. 
A number of studies have tried to determine velocity criteria that represent degrees of 
carotid stenosis and currently the most widely used parameter for the measurement of 
the degree of carotid constriction is the peek systolic velocity (PSV). However, the 
various PSV criteria published, applying several different parameters as well as the 
great variability among the laboratories, the instrumentations and the operators, has 
lead to controversy and discussion about which parameter and criteria should be used. 
No globally accepted criteria have hitherto been established. The fact that DUS is a 
highly operator dependant modality and the lack of standardized criteria have resulted 
in the use of different criteria and parameters by laboratories, according to local 
experience, radiological correlation and surgeons preferences and methods used for 
the measurement of the size of plaque (Oates et al, 2009). 
As far as diagnostic accuracy is concerned, several studies have showed DUS to be 
highly accurate in determining the degree of carotid stenosis. With the application of 
velocity criteria, DUS can identify greater than 70% stenosis with a sensitivity of 90% 
and specificity of 85% (Jahromi et al, 2005). The threshold of 70% is set by the 
endarterectomy trials mentioned before, that have shown that patients with greater 
than 70% stenosis benefited from endarterectomy. A meta-analysis of studies that 
compared different imaging modalities used for carotid atherosclerotic disease 
concluded that DUS is very accurate in determining the degree of stenosis when it is 
more than 70% or less than 50% (Wardlaw et al, 2006). The reason is unclear, but one 
possible explanation could be that the operator subconsciously rounds stenoses falling 
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between 50% and 69%, categorising up or down into the clinically more definite 
decision categories. 
Currently, DUS is the primary non-invasive imaging procedure for carotid stenosis 
severity assessment and treatment decision, and only in cases of unclear results a 
computed tomography angiography or magnetic resonance angiography is suggested 
for greater diagnostic accuracy (Bates et al, 2007). Because of its characteristics and 
its accuracy, it has also been effectively used for screening the population for carotid 
and peripheral arterial disease, as well as screening patients prior to CABG for carotid 
arterial disease (Ballard et al, 2007; Bates et al, 2007).  
Furthermore, new modalities of ultrasound have come in the foreground in carotid 
plaque investigation with promising results. Contrast enhanced ultrasound, with the 
use of microbubbles as blood pool agents, has been evaluated for assessing carotid 
plaque neovascularization, in a similar way that the technique is used for assessing 
tumour angiogenesis (Feinstein, 2006). Three-dimensional ultrasound has been tested 
for calculation of plaque volume and its assessment for response-to-treatment 
evaluation, with good intraobserver and interobserver reliabilities (Landry et al, 2004; 
Makris et al, 2011). Recent research has also looked at methods of three-dimensional 
investigation and analysis of carotid plaque for identification of changes in tissue 
components (Coleman et al, 2005). 
Computed tomography angiography 
Computed tomography angiography (CTA) is a non-invasive diagnostic modality 
with much potential, as fast helical CT scanners are now widely available. With the 
administration of iodine contrast, CTA can be used to grade the severity of stenosis 
and visualize the arterial lumen and vessel wall. In addition, a number of post-
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processing techniques allow the construction of 3D images of carotid arteries, though 
each has its strengths and limitations. For example shaded surface display 
reconstructions provide a 3D image of the outer vessel wall but no information about 
the residual lumen. Multiplanar and curved planar reformations facilitate 
reconstruction of the tortuous cervical arteries. Studies have reported very high 
accuracy of CTA in grading carotid stenosis. A meta-analysis of studies that 
compared CTA with conventional angiography showed sensitivity of 85% and 
specificity of 93% for detection of a 70% to 99% stenosis and 100% sensitivity and 
specificity for detection of complete carotid artery occlusion (Koelemay et al, 2004). 
It is noteworthy that a meta-analysis that compared all non-invasive modalities used 
for the carotid imaging concluded that CTA had the highest specificity of all (95%) 
for 70-99% stenosis (Wardlaw et al, 2006). As far as detection of complete carotid 
artery occlusion is concerned, CTA is more accurate than DUS, which can 
misdiagnose tight stenosis with minimal flow as occlusion (Koelemay et al, 2004). 
Since the positive predictive value of DUS in diagnosing total occlusion has been 
calculated being 86%, falling to 72% in symptomatic patients, it has been suggested 
that CTA is necessary for the discrimination between total occlusion and trickle flow 
(Lubezky et al, 1998). This is essential because tight stenosis and total occlusion are 
treated differently. 
As far as the plaque compositional information that CTA can provide, studies have 
shown good correlation between CTA findings and carotid plaque specimen 
histological analysis for plaque ulceration, calcification and lipid core with overall 
agreement of 75%. However, there is marked overlap in CT densities associated with 
haemorrhage, connective tissue and lipids (Wintermark et al, 2008). 
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CTA, when not used for reconstruction of 3D images, suffers the imaging limitations 
of angiography, as it cannot visualize the vessels in different planes as DUS does. The 
use of intravenous contrast agent limits its application in patients with renal 
insufficiency or cardiac failure, while it means potential risk for allergic reaction. It 
also exposes the patient to higher doses of ionizing radiation compared to 
conventional angiography. However, machines evolution and introduction of 256 and 
512-slice scanners could increase the accuracy, reliability and overall use of CTA for 
carotid atherosclerotic disease in the future. 
Magnetic resonance angiography 
Magnetic resonance angiography (MRA) and contrast-enhanced MRA (CEMRA) are 
increasingly used supplementary to duplex ultrasound or conventional angiography in 
the diagnosis of carotid artery stenosis. Time of flight (or “inflow”) methods, two or 
three dimensional, are non-invasive techniques which emphasize in blood flow, based 
on the different signal given by a material that has moved into the imaging volume. 
The gadolinium based contrast materials which are used in CEMRA are better 
tolerated than the iodinated media used for conventional angiography. Some of the 
drawbacks of time of flight techniques, especially signal loss near stenosis, have been 
overcome in CEMRA (Westwood et al, 2002). Among the imaging modalities 
available, CEMRA has the highest sensitivity (94%) for 70-99% stenosis while MRA 
has 88%. For that range of stenosis the specificity for CEMRA and MRA is shown to 
be 93% and 84% respectively. Less accurate but still better than the other techniques, 
CEMRA has been shown to have 77% sensitivity and 97% specificity for 50-69% 
stenosis, though the data for that range of stenosis are limited (Wardlaw et al, 2006). 
MRA is superior to DUS for the distinction between less than 70% stenosis and 70-
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99% stenosis, whereas for identifying total occlusion there is no significant difference 
in diagnostic accuracy between MRA and DUS (Nederkoorn et al, 2003). 
 
Fig 2.12, MRI investigation of carotid atherosclerotic plaque using gadolinium-based 
contrast agent; Precontrast image (left), contrast enhanced at bolus arrival (middle) and 75 
sec later (right) (adapted by Kerwin et al, 2006) 
There is ongoing research on the carotid plaque compositional details MRI can 
provide. By combining multiple different contrast weightings, MRI can distinguish 
different tissues of arterial wall or plaque. Good results have been reported for 
identification of lipid core, calcification and intraplaque haemorrhage, with satisfying 
intrareader and interscan reproducibility. Furthermore, dynamic contrast-enhanced 
magnetic resonance imaging, using gadolinium-based extracellular contrast agents, 
have been used for morphological and functional analysis of atherosclerotic plaque. 
This technique has been experimentally tested for atherosclerotic plaque inflammation 
identification and quantification with promising results (Hur et al, 2010). Moreover, 
increased image enhancement, quantified using kinetic modeling with a vascular 
component, has been well correlated with macrophage infiltration and 
neovascularization measured in histological plaque specimens (Kawahara et al, 2007; 
Kerwin et al, 2006) (Fig 2.12). However, the mechanism of image enhancement with 
gadolinium contrast agent remains unclear and the specificity of the technique for 
inflammation identification is not yet established. 
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Another suggested technique in magnetic resonance imaging for inflammation 
assessment is the use of ultrasmall superparamagnetic iron oxide particles (USPIOs) 
as contrast agents. Studies have shown that such particles are taken up by 
macrophages and generate a negative contrast in T2-weighted magnetic resonance 
imaging, which has been significantly correlated with degree of plaque macrophage 
infiltration (Trivedi et al, 2006). 
 Limitations of magnetic resonance imaging include the inability to perform due to 
implantable defibrillators and pacemakers and overestimation of carotid stenosis due 
to movement artifacts. MRA has advanced dramatically but it is still used more as a 
research tool than a diagnostic one. 
Positron emission tomography 
Positron emission tomography (PET) is a nuclear imaging technique, relatively new in 
carotid disease investigation. It can provide qualitative and qualitative information 
about atherosclerotic plaque, using radiolabeled ligands targeted in particular tissues 
or molecules. [
18
F]-fluorodeoxyglucose, a glucose analogue that is taken up by cells 
proportionally to their metabolism mimicking the biochemical behaviour of the 
natural glucose molecule, has been used to identify and quantify carotid 
atherosclerotic plaque inflammation (Rudd et al, 2010). In vitro and in vivo studies 
have reported high correlation between plaque 
18
FDG uptake compared to background 
uptake and degree of macrophage infiltration of the plaque (Rudd et al, 2002; 
Tawakol et al, 2006). A limitation of PET is its low spatial resolution (approximately 
5 mm) and investigation of arteries walls and plaques currently requires the 
combination with CT or high-resolution MRI, whilst new hybrid PET/CT machines 
are designed for the modality combination (Kai, 2010) (Fig 2.13). 
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Fig 2.13, Carotid plaque inflammation detected by [
18
F]-fluorodeoxyglucose PET (left), CT 
(middle) and FDG-PET/CT (right) (adapted by Kai, 2010) 
2.6.3 Management of carotid atherosclerotic disease 
The choice of appropriate and efficient treatment for carotid atherosclerotic disease 
depends on the degree of stenosis and the characteristics of the plaque found in the 
imaging investigation, taking into account the patient symptoms. 
Medical treatment 
All patients with carotid atherosclerotic disease, regardless of plans for 
revascularization by carotid endarterectomy or carotid artery stenting, should be 
treated medically to reduce stroke risk and alter modifiable risk factors. The optimal 
medical treatment consists of antihypertensive treatment (blood pressure goal is 
<140/90 mm Hg or for diabetic patients <130/80 mm Hg), smoking cessation, 
cholesterol level management, predominantly with statins  and lifestyle changes (LDL 
goal <100 mg/dL or <70 mg/dL in coronary heart disease high risk patients), diabetes 
control (goal HbA1c level <7%), weight reduction and antiplatelet agents (aspirin 
with or without extended-release dipyridamole or clopidogrel) (Safian, 2011). 
Despite the constant debate for the best treatment in border-line stenosis or in 
asymptomatic patients with severe stenosis, it is common ground that asymptomatic 
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patients with less than 60% of stenosis and symptomatic patients with less than 50% 
of stenosis are treated medically and followed up closely, and no revascularization 
procedure is planned. Furthermore, medical treatment alone is recommended for 
patients of greater stenosis but with high risk for revascularization procedure. Factors 
that increase risk of carotid endarterectomy include anatomical factors (bilateral 
severe carotid stenosis, inaccessible stenosis, hostile neck due to radiation therapy, 
cervical spine immobility), clinical factors (prior cranial nerve injury, severe 
cardiopulmonary disease, severe heart failure with ejection fraction <30%), impaired 
cerebral reserve, chronic kidney failure and age greater than 75 years. Factors that 
increase risk for carotid artery stenting include anatomical factors (complex aortic 
arch, brachiocephalic arterial disease, significant carotid plaque calcification, 
presence of thrombus), clinical factors (need of heart surgery within 6 weeks after 
stenting), impaired cerebral reserve, chronic kidney failure and age greater than 75 
years. 
In spite of the fact that the landmark carotid endarterectomy trials have confirmed 
superiority of surgical revascularization over medical treatment with antiplatelets, it is 
noteworthy that those studies did not include angiotensin-converting enzyme 
inhibitors and, most importantly, statins. This optimal medical treatment, which has 
been shown to efficiently reduce carotid atherosclerotic regression and intraplaque 
angiogenesis, has been proved to decrease the risk of cerebrovascular events and is 
currently used for primary and secondary prevention from stoke (Safian, 2011; Kang 
et al, 2004; Koutouzis et al, 2007). 
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Surgical treatment 
Carotid endarterectomy is the most common surgical procedure for carotid 
revascularization. Multicenter trials showed that symptomatic patients with carotid 
stenosis greater than 70% gain substantial benefit from carotid endarterectomy 
compared to those treated with best medical treatment. It has also been suggested that 
carotid endarterectomy should be considered in symptomatic patients with 50-69% 
stenosis with unstable, ulcerated and vulnerable plaque, where risk for stroke is 
significant. Furthermore, surgical treatment should be considered if comorbidities 
such as advanced age, diabetes mellitus and coronary artery disease are present, since 
they increase risk of stroke in patients treated medically, but not in those treated 
surgically. 
As far as patients with asymptomatic disease are concerned, endarterectomy trials 
reported that risk for stroke was reduced by 53% in patients with carotid artery 
stenosis greater than 60% that were treated surgically compared to patients treated 
medically (Asymptomatic Carotid Atherosclerosis Study, 1995). However, it is 
noteworthy that the 5-year risk for stroke in the asymptomatic patients that were not 
operated was only 11%. These results led to major increases in rates of 
endarterectomy for asymptomatic stenosis in some countries, most notably the United 
States, where approximate 150,000 endarterectomy are performed each year. Of these 
at least half are done for stenoses that have never been symptomatic. In contrast, little 
change for asymptomatic stenosis has been noted in other countries such as the UK, 
where it was felt that the benefit did not justify the cost, as it was estimated that 40 
operations were needed to prevent 1 disabling or fatal stroke after 5 years (Rothwell 
& Goldstein, 2004). 
61 
 
Current American Heart Association guidelines suggest carotid endarterectomy to be 
the best treatment for symptomatic patients with stenosis 50% to 99% if the risk for 
perioperative stroke or death is less than 6% and for asymptomatic patients with 60% 
to 99% stenosis if the risk is less than 3%, although some would not operate on 
asymptomatic plaque until it causes more than 80% artery stenosis (Table 2.1). 
Patient‟s life expectancy should exceed 5 years and his age should be between 40 and 
75 tears (Bates et al, 2007). If patient is considered of high risk for endarterectomy 
because of anatomical and clinical factors mentioned previously, alternative treatment 
(medical or carotid artery stenting) is recommended. 
 
Cardiovascular Wound Neurological Carotid artery  
Hypertension 
(20%) 
Infection (1%) 
Hyperperfusion 
syndrome 
Carotid artery 
thrombosis 
Death (1%) 
Hypotension (5%) Hematoma (5%) 
Intracerebral 
haemorrhage 
Carotid artery 
dissection 
 
Myocardial 
infarction (1%) 
 
Cranial nerve 
injury (7%) 
Restenosis (5%-
10%) 
 
  Seizures   
  Stroke (2%-6%)   
 
Table 2.1, Potential complications of carotid endarterectomy 
Carotid endarterectomy has evolved during the last decades from a complex major 
surgical procedure to a frequently performed intervention with minimal morbidity and 
mortality and it is proved to be very efficient treatment for severe symptomatic or 
asymptomatic carotid stenosis. 
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Carotid angioplasty and stenting 
Carotid angioplasty and stenting represents a new alternative revascularization 
treatment of carotid atherosclerotic disease. 
The first balloon angioplasty in carotid stenosis was performed in 1979 but the 
enthusiasm of medical community was quickly limited by the relatively high 
incidence of periprocedural embolic stroke. However, improvements in technique and 
equipment as well as the utilization of embolic protection devices for removal of 
embolic debris generated during the procedure have made carotid artery stenting a 
reasonable alternative treatment, especially for patients at high risk for surgery. 
With this technique, general anesthesia and its complications are avoided. It is usually 
performed via a catheter insertion at femoral artery, or in case of an anomalous left 
carotid artery at brachial or radial artery, avoiding incision in the neck and subsequent 
cranial and cutaneous nerve damage. Hospital admission and recovery time after 
endovascular treatment is usually less than with surgery, reducing healthcare costs.  
However one has to be aware of possible complications of carotid stenting (Table 2.2) 
as well as of the anatomical and clinical contradictions previously mentioned 
(tortuosity of aortic arch, heavy lesion calcification, life expectancy < 5 years etc). 
Carotid stenting is currently recommended for patients of high risk for surgery with 
symptomatic stenosis greater than 50% and asymptomatic stenosis greater than 80%. 
A randomized trial comparing carotid stenting and carotid endarterectomy in high risk 
for surgery patients (SAPPHIRE trial) reported less major adverse cardiovascular 
events (MACE) in 30-day period after revascularization procedure for carotid stenting 
compared to carotid endarterectomy. MACE incidence after 1 year remained 
significantly lower after stenting comparing to endarterectomy and stroke after 3 
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years rate was found around 1.2% per year for both surgery and stenting, nearly 5 
times lower than the rate for those treated medically (Safian, 2011). 
Cardiovascular Carotid artery Neurological General 
Vasovagal reaction (5%-
10%) Dissection (<1%) TIA (1%–2%) 
Access site injury 
(5%) 
Vasodepressor reaction 
(5%–10%) Thrombosis (<1%) Stroke (2%–3%) 
Blood transfusion 
(2%–3%) 
Myocardial infarction 
(1%) Perforation (<1%) 
Intracranial 
haemorrhage (<1%) 
Contrast 
nephropathy (2%) 
 ECA stenosis or 
occlusion (5%–10%) 
Hyperperfusion 
syndrome (<1%) 
Contrast reactions 
(1%) 
 Transient vasospasm 
(10%–15%) 
Seizures (<1%) Death (1%) 
 Restenosis (3%–5%)   
 
Table 2.2, Potential complications of carotid artery stenting 
Numerous registries for carotid stenting since then in more than 12,000 patients have 
reported a MACE in 30 days rate ranging from 3.8% to 8.5%. 
A recently completed multicenter randomized trial which compared carotid 
endarterectomy and carotid stenting in symptomatic and asymptomatic patients with 
greater than 70% stenosis (assessed by ultrasound) with normal surgery risk (CREST) 
reported no significant difference in rates of primary trial end point events (i.e. stroke, 
myocardial infarction or death during the periprocedural period or ipsilateral stroke 
within 4 years) between surgery and stenting (7.2% for stenting vs 6.8% for 
endarterectomy). However, a higher risk of stroke for stenting and a higher risk of 
myocardial infarction for endarterectomy were noted. Particularly in symptomatic 
patients the risk of stroke and death was significantly higher for stenting (6%) than 
endarterectomy (3.2%) (Mantese et al, 2010). 
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Further studies are needed and several randomized trials are running to assess long-
term therapeutic effect of carotid artery stenting and maybe adjust management 
guidelines for carotid atherosclerotic disease.  
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Chapter III 
Carotid plaque size assessment with Ultrasound 
A review of the literature 
3.1 Introduction 
Among the characteristics of an atherosclerotic plaque in any artery, coronary, carotid 
or other, its size is the one that has been widely correlated with the severity of the 
disease and has been assessed with various diagnostic methods even at the time of 
angiography.  
When angiography was the main imaging tool for carotid disease assessment, plaque 
size and degree of stenosis were the only measurable parameters and every 
management and therapeutic decision was based on that measurement. Whether a 
patient would have an endarterectomy operation or would receive medical treatment 
was decided upon the presence of symptoms and the determination of the degree of 
stenosis using angiography. Even nowadays that ultrasound has become the routine 
method for assessing carotid atherosclerotic disease and new ways of assessing the 
plaque have emerged, the degree of the stenosis remains the primary characteristic of 
plaque to be assessed for disease classification and progression monitoring. However, 
there are still ongoing debates and confusion among the vascular surgeons and 
technologists about the methods used to measure or calculate the degree of the 
stenosis. 
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3.2 The angiographic trials and the 70% cut-off 
In the decade of the 80s the carotid endarterectomy was one of the most commonly 
performed operations in the United States. By that time, the overall risk of surgery 
had not been investigated thoroughly and criticism about the necessity of surgical 
treatment in certain groups of patients had arisen. In addition to that, there was 
discussion about the relationship of the degree of stenosis with the risk of 
symptomatic disease, as it was common knowledge that also small plaques which 
caused minor or mild stenosis, can also be responsible for TIA or stroke by ulceration 
and thromboembolism (Warlow, 1984). 
In „90s, with x-ray angiography still being the main diagnostic method for measuring 
stenosis at carotid arteries, medical community tried to objectify the way the disease 
was approached as far as the size of the plaque was concerned. Establishment of 
criteria that would determine which patient would benefit from surgical treatment and 
which should be treated medically with antiplatelet and occasionally antihypertensive 
and antihyperlipidaemic agents was necessary. Two major trials were conducted, one 
in United States and Canada (North American Symptomatic Carotid Endarterectomy 
Trial, 1991) and one in Europe (European Carotid Surgery Trial, 1998). In the North 
American Symptomatic Carotid Endarterectomy Trial (NASCET), 2885 patients were 
randomized in 106 centres over a period of 9 years to optimal medical treatment of 
that time and medical plus surgical treatment. The European Carotid Surgery Trial 
was conducted from 1981 until 1994 in 100 centres in Europe; during that period 
3024 patients with symptomatic carotid disease were randomized to best medical 
treatment and carotid endarterectomy after medical treatment. 
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The results of these trials regarding the operative risk and the groups most benefiting 
from surgery were of great importance for the way the disease would be approached 
the years to follow. 
Both trials concluded in favour of surgical treatment in cases of severe stenosis, i.e. 
70-99%. According to ECST the highest risk for perioperative stroke was observed in 
patients with moderate stenosis (9.5%) as compared to those with severe stenosis 
(3.8%). In more detail, the risk was increased in female (10.4% vs 5.8% in male), in 
patients with peripheral vascular disease, in hypertensive patients and in patients 
presented with hemispheric TIA as a sole symptom (9.1% vs 6.3% in hemispheric 
stoke and 3.2% in retinal events). One third of stokes/deaths in NASCET occurred in 
the first post-operative day and the 86% of the rest within 7 days of surgery. 
Furthermore, NASCET reported association of operative risk and morphology of 
carotid plaque (5.5% for irregular vs 3.7% for smooth plaques). Wound complication 
(haematoma, infection etc) were reported in 9.3% and cranial nerve injuries in 8.6% 
in NASCET, though all were mild with full recovery (Naylor et al, 2003). 
Interestingly, according to NASCET, patients with smaller plaques (50-69%) gained a 
small but significant benefit from surgery if they match a particular profile (male, 
presenting with stroke, with hemispheric rather than retinal symptoms). On the other 
hand, ECST did not report any benefit in cases of mild stenosis. However, it should be 
stated that the two trials differ in some aspects of methodology, the most significant 
difference being the method used to measure carotid constriction. In ECST the 
minimum residual luminal diameter was compared with the estimated artery wall-to-
wall diameter at that point, whereas in NASCET the ratio of the smallest residual 
luminal diameter over the distal disease-free point diameter was used (Fig 3.1). The 
two methods produce different degree of stenosis for a particular case; for example, a 
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70% stenosis as measured using the NASCET method is measured as 85% stenosis 
when ECST method is used (Naylor et al, 2003; Nicolaides et al, 1996). Likewise, the 
50-69% group of NASCET (mild stenosis) is equivalent with the 70-79% group of 
ECST, so the results about the benefit of surgery are actually the same in both studies.  
 
Fig 3.1, Different methods for measuring carotid stenosis. NASCET uses the ratio of lumen 
diameter over distal diameter (L/D) while ECST uses the ration of lumen diameter over the 
arterial diameter at the point of constriction (L/V) 
At that time, with these methods being applied in angiography, NASCET method 
seemed to be more accurate and reproducible comparing to ECST method. Since it is 
the lumen of the vessel rather than the vessel wall that is visualized in angiography, 
calculation using the ECST method required estimation of the diameter of the artery, 
whether in the NASCET method one could just measure the luminal diameter of distal 
disease-free part of the vessel and compare it with the minimum luminal diameter of 
internal carotid artery. For that reason, NASCET method was more easily adopted for 
determining the degree of stenosis in a cerebrovascular angiogram. 
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3.3 Duplex ultrasound for carotid stenosis measurement 
When ultrasound was firstly introduced in clinical practice, in late 1970s and 1980s, it 
was used predominantly as a screening tool for selection of patients that would then 
have an angiography for determination of the degree of stenosis. At that time, because 
of the poor resolution of B-mode, the measurement of the stenosis was based on the 
spectral broadening and blood flow velocity measurement. Velocity criteria were 
therefore developed for classification of the stenosis in different categories. 
Over the years, as duplex ultrasonography evolved and imaging quality and accuracy 
of the machines were constantly improving and new modalities like colour Doppler 
were implemented, it gradually replaced angiography as the main diagnostic tool in 
the assessment of carotid atherosclerotic disease. The numerous limitations of 
conventional angiography along with its invasive character and the procedural stroke 
risk compared with the imaging possibilities, the safety for the patient and the 
convenience of ultrasound played a decisive role in that change of roles. Duplex 
ultrasound revealed new ways of approaching carotid plaque. The new modality 
offered visualization (colour Doppler mode) and quantification (pulse and continuous 
wave Doppler modes) of the blood flow, visualization of the lumen as well as the wall 
of the arteries and view of the arteries in cross section, all in a quick non-invasive 
way. 
As a result, by the year 2000, the decision for surgical or medical therapy of carotid 
disease in most patients was based solely on the results of duplex ultrasound scan as 
the only preoperative imaging study (Grant et al, 2003). 
Following the recommendation of the American and European angiographic trials in 
1990s for the significance of identification of greater than 50% and greater than 70% 
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of stenosis, vascular scientists tried to develop new velocity criteria for carotid 
stenosis grading. These criteria were always compared with angiographic 
measurement of the stenosis, ignoring the imaging limitations of the technique and the 
confusion over the angiographic methods of stenosis measurement. 
3.4 Controversy and confusion over velocity criteria 
Numerous sets of velocity criteria were proposed, giving different interpretations to 
the various flow velocities parameters (Moneta et al, 1995; Staikov et al, 2002; 
Thomas et al, 2002; Nicolaides et al, 1996; Elgersma et al, 1998; Hwang et al, 2002; 
Mittl et al, 1994; Nederkoorn et al, 2002; Zwiebel, 1987; AbuRahma et al, 1998; Filis 
et al, 2002; Robinson et al, 1988). The variation of these values is quite remarkable, 
but at some point it is justified due to the different scanners, protocols, settings like 
Doppler angle and techniques used in each center (Fig. 3.2). 
 
Fig 3.2, Variation of PSV cut-off for 70% stenosis (NASCET method) in several published 
criteria 
Furthermore, the different angiographic methods proposed by the angiographic trials 
worsened the confusion over the use of velocity criteria among vascular laboratories 
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and led to different calculation among the diagnostic centres and obstructed the 
standardization of DUS criteria. 
3.5 Consensus criteria 
In an effort to standardize criteria and technique for carotid stenosis ultrasound 
investigation, the Society of Radiologist in Ultrasound tried to arrive at a consensus 
about several issues (Grant et al, 2003). It was decided that Doppler was inaccurate 
for subcategorizing stenosis less than 50% and recommended that further stratification 
should apply only in greater constriction (50%-69%, >70% and occlusion). 
Furthermore, although the direct proportional relationship between increase of 
Doppler velocity and degree of stenosis was agreed, grading of the stenosis in deciles 
was considered inaccurate and operators were urged to characterize the stenosis as 
below or above a cut-off value. 
Recommendations were made regarding the parameters used for diagnosing and 
grading ICA stenosis, suggesting Peak Systolic Velocity (PSV) in ICA as the main 
one to be used, in addition to the presence of plaque on gray-scale and/or colour 
Doppler images. In cases of difficulty in diagnosing because of technical or clinical 
factors, additional parameters, like internal carotid artery / common carotid artery 
PSV (ICA/CCA PSV) ratio and ICA End Diastolic Velocity (ICA EDV) were agreed 
to be used. These ratios helped in normalization of proximal or distal effects in peak 
systolic velocity within the internal carotid artery, such as from any proximal 
pathology, in the proximal arteries or left ventricular function, aortic valve disease or 
from distal vascular disease in the distal carotid artery or cerebral vessels. Specific 
criteria and diagnostic thresholds were also proposed (Table 3.1). 
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Degree of stenosis ICA PSV (cm/sec) 
ICA/CCA PSV 
ratio 
ICA EDV 
(cm/sec) 
<50% <125 <2.0 <40 
50-69% 125-230 2.0-4.0 40-100 
>70% >230 >4.0 >100 
Near occlusion 
Variable or 
undetectable 
Variable Variable 
Total occlusion Undetectable N/A N/A 
 
Table 3.1, Society of Radiologists in Ultrasound consensus panel Doppler velocity criteria for 
diagnosis of internal carotid artery stenosis (Grant et al, 2003) 
It is noteworthy that the consensus conference did not make any recommendations 
regarding direct measurement of the stenosis in B-mode or reporting compositional or 
morphological details about the plaque. 
3.6 UK practice and new recommendations 
Despite the fact that in North America most of the vascular laboratories have 
complied with these consensus criteria, in Europe and particular in United Kingdom it 
seems that the variability in thresholds used in velocity criteria remained, increased by 
the continuing confusion and debate over the measurement method (Walker & 
Naylor, 2006). Furthermore, new velocity ratios were introduced since then, trying to 
overcome the limitations of PSV, which is not only depended on local constriction but 
also on any proximal or distal pathology. 
An audit for UK practice in diagnosing stenosis greater than 70% with DUS revealed 
the considerable variability in diagnostic thresholds among the vascular laboratories 
in UK as well the variation in the measurement method used (Walker & Naylor, 
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2006). The survey showed that diagnostic centers used different measuring method, 
between NASCET and ECST, sometimes even without being aware of which one, and 
thus different DUS thresholds for determining >70% stenosis were applied. It was 
also clear that there was a remarkable variety in the velocity criteria used to determine 
this stenosis, with a prevalence of a PSV threshold of >230 cm/s, which represents a 
>70% stenosis according to the Radiologists consensus panel, measured in the 
NASCET method (Fig 3.3). 
 
Fig 3.3, PSV and EDV criteria for diagnosing “stenosis >70%” in the UK; black triangle = 
NASCET measurement method, black circle = ECST measurement method, black square=do 
not know (Walker & Naylor, 2006) 
Although methods based on the measurement of blood flow velocities were 
considered reliable for estimating the degree of constriction of the carotid arteries, 
universally accepted criteria correlating blood flow velocity with stenosis were still 
lacking, preventing DUS from being the gold standard in clinical practice and 
replacing conventional angiography. Meanwhile new imaging modalities like CTA 
and MRA were rapidly evolving and becoming widely available, while advances in 
technology of ultrasound further improved B-mode resolution, providing new 
approaches for assessing the disease. 
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In 2008 a Joint Working Group was formed between the Vascular Society of Great 
Britain and Ireland and the Society of Vascular Technology of Great Britain and 
Ireland for developing new recommendations about ultrasound assessing and 
reporting carotid atherosclerotic disease (Oates et al, 2009). 
The group suggested the use of PSV in ICA in conjunction with two ratios, PSVR 
(PSV in ICA over PSV in CCA) and St. Mary‟s Ratio (PSV in ICA over EDV in 
CCA), proposing parameters thresholds for stenosis grading in <50%, 50%-70% and 
>70% stenosis and classification in deciles using St. Mary‟s Ratio (Table 3.2). 
According to the group‟s recommendation, agreement of at least two of these criteria 
increases the diagnostic confidence. 
Degree of stenosis ICA PSV (cm/sec) 
ICA/CCA PSV 
ratio 
St. Mary ratio 
ICAPSV/CCAEDV 
<50% <125 <2.0 <8 
50-59% 125-230 2.0-4.0 8-10 
60-69% 125-230 2.0-4.0 11-13 
70-79% >230 >4.0 14-21 
80-89% >230 >4.0 22-29 
>90 >400 >5.0 >30 
Near occlusion Variable Variable Variable 
Total occlusion Undetectable N/A N/A 
 
Table 3.2, Joint Working Group of Vascular Society and Society of Vascular Technology in 
Great Britain and Ireland velocity criteria for carotid stenosis assessment (Oates et al, 
2009) 
As far as the method of measurement is concerned, the group suggested the use of 
NASCET method, based on the fact that most surgeons in UK are familiar with this 
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method and is consistent with recommendations in USA and Australia. Furthermore, 
NASCET method would make comparison with other angiography-like methods, like 
CTA, easier. However, direct measurement using B-mode was not generally 
recommended, except for the case of large plaques in carotid bulb with diameter more 
than 10mm, in which ECST direct measurement method was recommended as 
NASCET method would falsely underestimate stenosis.  
Regarding reporting on plaque compositional and morphological characteristics, the 
joint group suggested limited qualitative reporting about plaque‟s exact position, 
length, morphology and calcification. 
3.7 B-mode direct measurement of carotid stenosis 
It is apparent that there is no common ground concerning the direct measurement of 
diameter reduction in B-mode in addition to velocity criteria for a more accurate 
estimation of the ICA stenosis. 
Velocity parameters have important limitations in a number of clinical conditions. 
Cardiac arrhythmia, aortic valve insufficiency, good collateral circulation, tandem 
plaques, carotid dilatation or aneurysm may result in underestimation of degree of 
stenosis. On the other hand, carotid coiling or kink, arteriovenous malformation, 
carotid-body tumours and contralateral severe stenosis or occlusion may lead to 
overestimation of stenosis (Zachrisson et al, 2001; Krejza et al, 2001; Spencer et al, 
2001). Slight errors in velocity cursor placement or selection of Doppler angle may 
also result in false measurements and calculations. Furthermore, studies have shown a 
good linear relationship between actual diameter and area measurements in plaque 
specimens and direct diameter and area measurements in ultrasound, especially in the 
transverse section (Jmor et al, 1999). 
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On the other hand, errors in angle determination, tortuous arteries and severe 
calcification are significant imaging limitations for direct B-mode measuring. 
Especially the longitudinal view for diameter measurement shows large variations 
among operators because of the difficulty of reproducing the angle of incidence (Jmor 
et al, 1999). 
It has been suggested that there is a strong correlation between B-mode and 
angiography stenosis measures and that the combination of B-mode stenosis 
measurement with velocity measurements can provide a more complete estimation of 
the stenosis and as a result a more accurate diagnosis of the disease (Rotstein et al, 
2002; MacKenzie et al, 2002). However, the accuracy of this suggestion is 
ambiguous, as other studies have showed that addition of B-mode diameter reduction 
measurement in DUS did not improve the accuracy of carotid stenosis beyond that 
from velocity criteria alone, when compared with angiography (Wardlaw & Lewis, 
2005). It is noteworthy that the disagreement in results of diameter measurements in 
DUS and DSA has been attributed to different imaging approach of the stenosis 
(“best” view of the stenosis on DUS may be different than that on DSA because of 
technical reasons) and different imaging potentials (DUS also visualizes the vessel 
wall while DSA only the lumen), which suggests that angiography cannot be a 
reference for evaluating B-mode measurement (Wardlaw & Lewis, 2005). The issue 
about the method used for calculating the diameter reduction in ultrasound also 
remains unclear. 
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Chapter IV 
Identification of the vulnerable plaque using Ultrasound 
A review of the literature 
4.1 Looking beyond the size 
In the „90s three major multicenter clinical trials, the North American Symptomatic 
Carotid Endarterectomy Trial (NASCET), the European Carotid Surgery Trial 
(ECST) and the Asymptomatic Carotid Atherosclerosis Study (ACAS) tried to set the 
criteria for selection of patients that would be benefited from surgical rather than 
medical treatment of carotid atherosclerotic disease. 
Despite using different methods of assessing carotid stenosis and different patients‟ 
categorization, NASCET and ECST studies, which both looked at symptomatic 
patients, associated stroke risk with the severity of carotid stenosis, suggesting patient 
selection for endarterectomy based on plaque size. More specifically, they reported an 
absolute risk reduction of 16% (p<0.001) in symptomatic patients with greater than 
70% stenosis who were treated surgically after a 5-year follow-up. In patients with 
mild stenosis (less than 50%) the risk of the surgery itself outweighed its benefits. In 
the “grey-zone” of moderate disease (50-70% stenosis) the benefit of surgery 
outweighed the risk, it was considered however more modest, offering a risk 
reduction of 4-6% (Rothwell et al, 2003). 
Although NASCET and ECST studies both set the 70% cut-off for endarterectomy 
patient selection, the data analysis show that classification of carotid atherosclerotic 
disease based on degree of stenosis enables prediction of one out of four strokes in 
symptomatic patients and only one out of ten strokes in asymptomatic patients. In the 
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ECST trial, 43.8% of the 3,018 participants with symptomatic carotid disease had less 
than 30% stenosis. The 70% cut-off point for surgical benefit for symptomatic 
patients was later doubted by studies such as the one carried out by Barnett and 
colleagues. This group reported a significantly lower (p=0.045) 5-year rate of stroke 
in symptomatic patients with 50% to 70% stenosis that were treated surgically 
comparing to patients with same degree of stenosis that received medical treatment 
(Barnett et al, 1998). Furthermore, the fact that the benefit from carotid 
endarterectomy significantly decreased with delayed surgery, whereas it was unlikely 
that the size of the plaque had changed in the meantime, confirmed that there were 
other plaque characteristics other than its size or the stenosis they cause that were 
important in identifying patients at high risk of stroke (Rothwell et al, 2004). 
In asymptomatic patients, the association of stroke rate with the degree of stenosis 
was not that clear. Despite the fact that earlier studies suggested slightly greater risk 
(2-5%) in patients with plaques causing greater than 75% stenosis comparing to less 
severe disease (risk of stroke 1%) (Autret et al, 1987; Meissner et al, 1987), in the 
ACAS study such association was not reported (Endarterectomy for asymptomatic 
carotid artery stenosis. Executive Committee for the Asymptomatic Carotid 
Atherosclerosis Study, 1995) (Table 4.1). A small stroke risk in severe stenosis in 
asymptomatic patients was also confirmed by Longstreth et al in 1998. After having 
scanned 5,441 participants they found a 5% 5-year risk for stroke in patients with 
greater than 70% stenosis, similar to the stroke risk of patients with moderate stenosis 
in ACAS study (Longstreth et al, 1998). Due to the mixed data, there was much 
uncertainty about the net benefits of surgical treatment for asymptomatic patients, 
however, more and more studies tended to encourage surgical treatment in 
asymptomatic patients with severe disease. The Asymptomatic Carotid Surgery Trial 
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in UK has reported a significant decrease of the net 5-year stroke risk (6% from 12%) 
after immediate carotid endarterectomy in asymptomatic patients younger than 75 
years old with greater than 70% stenosis comparing to deferral endarterectomy 
(Halliday et al, 2004). 
Stenosis NASCET ECST ACAS 
60%-69% 13% 11% 6% 
70%-79% 21% 9% 5% 
80%-89% 27% 21% NS 
90%-99% 35% 32% NS 
80%-99% 31% 24% 3% 
Table 4.1, Relationship between severity of stenosis and stroke rate (Golledge et al, 2000) 
Recent studies have been looking beyond practice of assessing the diseases strictly 
based on the size of plaque and have suggested the classification of carotid plaques 
into two types: a stable plaque that can increase in size and severely decrease the 
lumen, possibly causing hypoperfusion, but is unlike to rupture and an unstable that, 
despite possibly being of smaller caliber, is more prone to rupture and is related to a 
higher risk of embolization and carotid occlusion. This classification is consistent 
with the fact that the majority of strokes appear to have resulted from embolization 
from atherosclerotic plaques causing only mild or moderate artery stenosis or acute 
occlusion and propagation of thrombus distally rather than hypoperfusion due to 
lumen stenosis (Seeger et al, 1995; Golledge et al, 2000). It is noteworthy that in the 
early stages of atherosclerotic plaque formation, the carotid artery wall can remodel 
so the luminal size is not compromised (Pasterkamp et al, 2004). This can lead to 
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significant plaque growth, likely to rupture and lead to embolization, without 
significant stenosis of the artery, hence not treated as a high-risk plaque by the 
traditional, degree-of-stenosis based assessment of the disease. 
Early identification of the unstable plaque in patients with less than 70% of stenosis, 
the common cut-off in patients‟ selection for revascularization procedures, could 
improve patient selection and prevent future strokes (Grønholdt et al, 2001). 
Furthermore, screening patients with arterial disease risk factors or patients suffering 
from cardiovascular disease but asymptomatic for cerebrovascular disease and 
classification of plaque as unstable or high-risk could potentially lead in better 
management of the disease, more aggressive medical treatment and possibly surgical 
treatment for more efficient stroke prevention. 
4.2 The vulnerable plaque 
Vulnerable or unstable plaque is the atherosclerotic plaque that has a high possibility 
to cause thrombotic complications such as stroke or a plaque that tends to progress 
rapidly (Saam et al, 2007). Studies have identified certain morphological and 
compositional characteristics that classify a plaque as vulnerable (Fig 4.1). 
Fibrous cap 
In studies looking at histological analysis of post-endarterectomy specimens, plaques 
associated with cerebrovascular symptoms have been found having a much thinner 
fibrous cap, significantly infiltrated by macrophages and lymphocytes and with 
decreased smooth muscle cell content (Golledge et al, 2000; Devuyst et al, 2005). A 
thin fibrous cap (<650 μm) has been shown to increase the circumferential stress on 
the plaque and thus make it more prone to rupture and lead to thrombosis and 
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embolism (Waki et al, 2003). As atherosclerosis progresses, foam cell disintegration, 
smooth muscle cell apoptosis and increased metalloproteinase release by activated 
leukocyte, result in collagen degradation and fibrous cap thinning (Falk, 2006). T-
lymphocytes also play significant role in fibrous cap thinning, by inducing the 
macrophage metalloproteinase secretion and promoting smooth muscle cell apoptosis 
via interleukin-1 production. 
Lipid-rich core 
Lipoproteins play an important role in atherosclerotic plaque formation, accumulating 
in the subendothelial area in the early stages, following endothelium dysfunction and 
injury, where they are ingested by macrophages, creating the foam cells. The 
apoptosis of foam cells leaves extracellular lipid, cholesterol crystals and necrotic 
debris, which are the main component of the necrotic core of the atheromatic plaque 
(Virmani et al, 2000; Thim et al, 2008). Lipoproteins can also contribute to the 
necrotic core formation by direct accumulation in the lesion without being ingested by 
macrophages or by the cholesterol-rich erythrocyte membranes in case of intraplaque 
haemorrhage (Thim et al, 2008).  
Lipid and cholesterol laden plaques with low levels of collagen have indicated greater 
instability and higher probability for rupture (Seeger et al, 1995). In coronary arteries 
plaques, the significance of the size of the lipid core has been well established by 
postmortem and atherectomy studies and several endarterectomy studies have 
reported increased lipid-rich core (usually more than 25%) in symptomatic patients 
(Davies et al, 1993; Grønholdt et al, 2002; Virmani et al, 2000). The necrotic core‟s 
proximity to the lumen has also been associated with increased risk of ischaemic 
events, as it makes it easier for the core to be exposed after the fibrous cap thinning, 
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leading to rupture and creation of thrombus and possibly embolization (Bassiouny et 
al, 1997).  
 
Fig 4.1, Characteristics of the vulnerable atherosclerotic plaque 
Intraplaque haemorrhage 
Subintimal intraplaque haemorrhage, occurring from cracks or fissures that originate 
from the luminal surface of the plaque or from the rupture of vasa vasorum, has been 
suggested to predispose to plaque instability (Bassiouny et al, 1997; Alexander-Sefre 
et al, 2003; Saam et al, 2007). Haemorrhage is directly connected with plaque 
neovascularization, as new immature microvessels are more fragile and prone to lead 
to intraplaque haemorrhage. 
Inflammation 
Macrophage infiltration of the atherosclerotic plaque has been seen as a feature of 
vulnerable atherosclerotic plaque for over a decade, predominantly for coronary 
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arteries. Macrophages cause the release of lytic enzymes such as collagenase, 
gelatinase and stromelysin which degrade fibrous cap matrix proteins and make it 
more prone to rupture (Moreno et al, 1994). Furthermore, plaque macrophage take up 
the atherogenic low-density lipoprotein, forming foam cells laden that constitute 
plaque‟s core and lead on lesion progression (Kai, 2010). Carotid plaque specimens 
from patients with symptomatic cerebrovascular disease have been reported indicating 
significantly greater inflammatory activity than specimens from asymptomatic 
patients (Spagnoli et al, 2004). Leukocyte recruitment depends on the expression of 
adhesion molecules on the intimal surface as well as the release of soluble factors. It 
requires interaction between endothelial selectins and leukocyte ligands and it is 
further promoted by monocyte chemotactic protein and binding of leukocyte CD18 
and endothelial adhesion molecules such as ICAM-1 and VCAM-1. Whether 
leukocytes enter the plaque via the intima or the vasa vasorum of the vessel wall or 
the new vessels created within the plaque remains unclear. However, studies on 
coronary plaques have suggested neovessels being a major source of inflammatory 
factors, reporting high leukocyte adhesion factors‟ expression in those immature 
vessels (O‟Brien et al, 1996). 
Plaque neovascularization 
Vasa vasorum are small vessels responsible for the nourishment and the draining of 
the outer components of vessel wall of most muscular and conduit arteries and veins. 
They vary in size and structure depending on the size and the oxygen need of the 
vessel they nourish. In large arteries and veins, or in cases of atherosclerotic arteries, 
the vasa vasorum extend into the outer layer of the media (Williams & Heistad, 1996). 
In non diseased arteries the intima is nourished by diffusion from the lumen. 
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However, as atherosclerotic disease progresses and the intima becomes thicker, 
oxygen diffusion is impaired and vasa vasorum become the main source of 
nourishment for the whole vessel wall. Neovascularization is the creation of new 
blood vessels resulting in the formation of a neovascular network particularly in 
atherosclerosis of capillaries (Fig 4.2). Angiogenesis occurs when intima thickens 
more than 500 μm, mainly because of the hypoxic state caused by the atherosclerotic 
lesion which triggers the production of angiogenic factors like vascular endothelial 
growth factor (VEGF). Apart from hypoxia, hypertension and hypercholesterolemia 
have also been characterized as angiogenic stimuli (Langheinrich et al, 2007). 
 
Fig 4.2, Photomicrograph display of CD31-stained tissue samples. Red arrows show plaque 
microvessels (adapted by Shah et al, 2007) 
Atherosclerotic plaque neovessels, alternatively named as vasa plaquorum in recent 
literature, originate predominantly from the adventitial vasa vasorum and secondarily 
(< 5%) from vessel lumen (Galis & Lessner, 2009). Neovasculature created by 
spouting growth of adventitial vasa vasorum has been correlated with increased 
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inflammation, great lipid core and severe stenosis, whereas lumen originated 
neovascularization has been correlated with smaller plaques and intraplaque 
haemorrhage (Moreno et al, 2006). 
Carotid plaque neovascularization has been associated with plaque vulnerability. In a 
study in 1999 by McCarthy and colleagues, the histological analysis of plaques taken 
from symptomatic and asymptomatic patients showed significantly higher neovessel 
density for plaques from symptomatic patients (4 vessels/mm
2
) compared with those 
from asymptomatic (0.7 vessels/mm
2
, p<0.0004). Apart from the number of plaque 
microvessels, their morphology also differs in symptomatic and asymptomatic 
patients. Symptomatic lesions have been associated with larger, irregular and 
immature (lacking smooth cell coating) neovessels comparing to asymptomatic 
plaques neovasculature. Adjacent to microvessels macrophage infiltration and high 
VEGF expression have also been correlated with symptomatic patients (Dunmore et 
al, 2007). Furthermore, the number of new vessels within the plaque fibrous cap has 
been reported significantly larger in symptomatic lesions comparing with 
asymptomatic (McCarthy et al, 1999). 
Artery remodeling 
Remodeling of coronary arteries in the site of an atherosclerotic plaque, namely 
compensatory enlargement that permits growth of the plaque without reduction of 
luminal area, has been associated with plaque‟s likelihood to rupture and thus plaque 
vulnerability. The artery remodeling has been associated with higher lipid content and 
macrophage count in the plaque, both markers of plaque vulnerability as has been 
mentioned (Varnava et al, 2002). Carotid artery remodeling is commonly seen in sites 
of atherosclerotic plaque creation. 
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Focal calcification 
Atherosclerotic plaques with large calcific deposits are considered stable and unlikely 
to rupture. A recent systematic review of studies looking at characteristics of 
vulnerable plaque concluded that clinically symptomatic carotid plaques had a lower 
degree calcification volume, weight or percentage (Kwee, 2010). However, it should 
be noted that studies on coronary atherosclerotic plaques have suggested that calcified 
nodules near the fibrous cap that protrude into the lumen can result in plaque rupture 
and therefore focal calcification should be seen as a minor criterion for plaque 
vulnerability (Schaar et al, 2004; Falk, 2006; Saam et al, 2007). 
Shear stress 
The fact that atherosclerotic plaques are not evenly distributed in the arterial system, 
but are formed in areas such as inner curvatures of non-branching arteries or opposite 
to the flow divider of bifurcations, has lead to the association of atherosclerosis 
occurrence with local haemodynamic factors and particularly wall shear stress. Shear 
stress is the drag force arising from the friction between two layers in a fluid, induced 
by the difference in movement of the two layers and the fluid‟s viscosity, but it also 
arises at the interplay between blood and endothelial layer (Helderman et al, 2007). 
Observational studies in human and animals have shown that regions in the arterial 
network with low (< 1.5 N/m
2
) or oscillating shear stress are more susceptible to 
atherosclerosis compared to regions with normal or high shear stress, which seems to 
act atheroprotectively to artery wall. Low shear stress has been associated with many 
plaque vulnerability characteristics, such as greater lipid cores, fewer smooth muscle 
cells and collagen in lesion cap, intraplaque haemorrhage and outward remodelling. It 
has been suggested that shear stress alters the inflammatory gene expression of 
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endothelial cells and increases the permeability of endothelium to lipoproteins and 
macrophages. Studies have confirmed increased expression of VCAM-1 and other 
atherosclerosis markers such as IL-6 and CRP in lowered shear stress regions (Cheng 
et al, 2006; Li et al, 2008). 
4.3 Assessment of plaque composition using Duplex 
Ultrasound 
In the DUS imaging an atheromatic plaque can be classified according to certain 
parameters, such as echogenicity (echolucent or echogenic), texture (homogeneous 
and heterogeneous) and surface (regular, ulceration) (Hennerici et al, 1998). There 
have been efforts over the years for correlation of these sonographic characteristics 
with the actual composition of the plaque in a way that duplex ultrasound would 
provide compositional information for better vulnerable plaque identification. 
Plaque echogenicity 
Plaque echogenicity (i.e. how “bright” or “dark” a plaque appears in the ultrasound) is 
the most commonly used imaging characteristic of the carotid plaque since Duplex 
Ultrasound began to be used for the assessment of plaque composition. In 1988, Gray-
Weale classification of carotid plaques according to their echogenicity was 
established and has widely been used for plaque description (Gray-Weale et al, 1988). 
According to that classification, carotid plaques were divided into four groups; 
echolucent, mainly echolucent, mainly echogenic and echogenic. A great number of 
studies have since then looked at the clinical manifestation of carotid atherosclerotic 
disease with plaques of different echogenicity. Most of them have reported 
significantly greater relevant risk for cerebrovascular symptoms in patients with 
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echolucent plaques, regardless of the degree of the stenosis caused by the plaque 
(Polak et al, 1998; Mathiesen et al, 2001). It has been suggested that plaque 
echolucency should be considered as an independent risk factor for ischaemic stroke, 
regardless of other cardiovascular risk factors (Grønholdt et al, 2001). However, in 
asymptomatic patients the association of plaque echogenicity and risk for stroke has 
been reported to be less significant (Halliday et al, 2004). 
 
Fig 4.3, Echolucent carotid plaque (arrow) 
Histological analysis of plaque specimens have reported that echolucent plaques 
contain more soft tissue (lipid and haemorrhage) while echogenic are primarily 
composed of fibrous tissue and calcification (Grønholdt et al, 1997). However, the 
poor reproducibility of subjective echogenic classification among studies, possibly 
because of the inter-observer variability of the methods, the high operator dependence 
and the limited soft tissue contrast, has led to conflicts over the accuracy of ultrasound 
in plaque composition assessment (Montauban van Swijndregt et al, 1998; Saam et al, 
2007). This subjectivity obstacle was partially overcome by development of methods 
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that normalized ultrasound images and objectively characterized the plaque, like the 
grey scale median method (GSM) (Elatrozy et al, 1998b). Since the introduction of 
the grey scale median method as an objective computerized way for the 
characterization of plaque echogenicity, studies began correlating symptomatology 
and histology with this value in an effort to establish a cut-off point that would 
identify vulnerable plaque. 
 
Fig 4.4, Two echogenic plaques (arrows) 
Grey scale median 
High correlation was reported by numerous studies between low GSM value (lower 
than 32, a cut-off many studies have used) and symptomatology, in many cases 
confirmed with cerebral infarction identification in CT scans (el-Barghouty et al, 
1996; Falkowski et al, 2004; Wijeyaratne et al, 2003; Grogan et al, 2005). The 
relative risk for ischaemic stroke was reported to be higher for low GSM comparing 
to degree of stenosis (Grønholdt et al, 2001). With time, more sophisticated methods 
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for computerized analysis of plaque echogenicity were developed, calculating the 
grey scale median for small regions of interest on carotid plaques with similar results 
regarding the relationship of GSM value and symptomatology (Sztajzel et al, 2005). 
Another grey scale image parameter that has been investigated, the percentage of 
pixels with gray scale value less than 40 (P40), has also been found to be significant 
for distinguishing symptomatic and asymptomatic plaques (Pedro et al, 2000). 
GSM value was also calculated in 3D duplex ultrasound images, showing good 
correlation with symptomatology for plaques causing less than 70% stenosis 
(Heliopoulos et al, 2008). 
Regarding the ability of ultrasound to distinguish tissue components of atherosclerotic 
plaque using computerized analysis of plaque echogenicity, results were mixed for 
different tissues. Initial results showed only little agreement between plaque GSM and 
histology findings, however further studies associated plaque low echogenicity with 
intraplaque haemorrhage and high echogenicity with calcification, (Aly & Bishop, 
2000; Denzel et al, 2003; Tegos et al, 2000). New techniques, using stratified 
grayscale measurement or pixel distribution analysis have been suggested good 
correlation with both symptomatology and histology (Lal et al, 2006; Sztajzel et al, 
2005). Until today, there is no consensus about specific GSM threshold for vulnerable 
plaque identification or other method for assessing plaque vulnerability based on 
echogenicity. 
Plaque homogeneity 
Heterogeneous plaques have been associated with higher incidence of symptoms than 
homogeneous plaques, regardless the severity of stenosis (AbuRahma et al, 2002). 
Visual characterization of plaque homogeneity as well as characterization based on 
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computerized methods for assessing grey scale images has shown prevalence of 
heterogeneous plaques in symptomatic patients (el-Barghouty et al, 1996; 
Wijeyaratne et al, 2003). Among the heterogeneous plaques the echolucent area is 
usually juxtaluminal in symptomatic patients and basal in asymptomatic patients, 
whereas in homogeneous plaques the echogenic cap has been well correlated with 
asymptomatic patients and negative CT while plaque surface disruption has been 
related with symptomatic patients and positive CT results (Pedro et al, 2000). 
 
Fig 4.5, An homogeneous carotid plaque with regular surface 
Plaque irregularity 
Plaque irregularity has been shown to be another risk factor for cerebrovascular 
symptomatology and particularly ischaemic stroke (Kwee et al, 2008). In 2006, 
Prabhakaran and colleagues assessed with ultrasound more than a thousand carotid 
plaques, and after following up the patients for more than 6 years they reported nearly 
threefold stroke risk in patients with irregular plaques (hazard ration 2.7) 
(Prabhakaran et al, 2006). A similar study in Japan in elderly people showed high 
correlation between plaque irregularity and risk for ischaemic stroke (Kitamura et al, 
2004). 
94 
 
 
Fig 4.6, An irregular, heterogeneous carotid plaque 
4.4 Fibrous cap thickness 
Fibrous cap thinning has been suggested to increase the circumferential stress of 
fibrous cap and thus make the plaque more prone to rupture. There is ongoing 
research on ultrasound methods for fibrous cap thickening measurements but initial 
results using both B-mode ultrasound and integrated ultrasound backscatter (IBS) 
analysis show good correlation with histological analysis (Waki et al, 2003; Devuyst 
et al, 2005). However, the axial resolution which ranges between 200 to 600 μm for 
most ultrasound instruments is an important limitation for measurements of such 
small calibre. 
4.5 Intima-media thickness 
Carotid intima-media thickness (IMT) is considered a significant marker of 
atherosclerotic burden and, despite not being a characteristic of the plaque per se, it 
provides useful information about patient risk stratification. Carotid IMT has been 
associated with cerebrovascular symptomatology and hence plaque vulnerability. The 
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Rotterdam study, in which 6,913 participants previously asymptomatic of 
cerebrovascular disease were followed-up for more than 6 years, reported strong 
relationship between ultrasound measured IMT and risk of stroke, independently of 
other cardiovascular factors (Hollander et al, 2003). Several follow-up studies have 
reached similar results concerning IMT importance (Kitamura et al, 2004). 
4.6 Plaque angiogenesis 
Since the establishment of atherosclerotic plaque neovascularization as a feature of 
vulnerable and symptomatic plaque there have been efforts to visualize and quantify 
plaque angiogenesis. Ultrasound, particularly contrast enhanced ultrasound, as well as 
magnetic resonance imaging, has been used for assessing plaque angiogenesis. 
Carotid B-mode ultrasound has predominantly been used for plaque identification and 
carotid stenosis and intima-media thickness measurement. For plaque angiogenesis 
identification and quantification, contrast enhanced ultrasound (CEUS) has been 
suggested showing good results compared to plaque histology analysis and patient 
symptomatology. Acoustically reflective microbubbles have been used as contrast 
agents for enhancement of carotid lumen and plaque morphology, improvement of 
IMT measurement and identification of adventitial vasa vasorum and plaque 
neovasculature (Feinstein, 2006). A variety of contrast agents have been used for 
neovascularization imaging, including perflutren protein type-A microspheres 
(Optison, GE Healthcare, Little Chalfont, Buckinghamshire, UK), perflutren lipid 
microspheres (Definity, Bristol-Myers Squibb Medical Imaging, Billerica, 
Massachusetts), and phospholipidstabilized microspheres of sulfur hexafluoride 
(SonoVue, Bracco Altana Pharma, Konstanz, Germany) (Staub et al, 2010). For 
comparison with histology, microvessels in post-endarterectomy carotid plaque 
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specimens are identified using several immunohistochemical markers, like CD31, 
CD34 antibody and VEGF antibodies (Shah et al, 2007). 
Histological analysis of post-endarterectomy plaque specimens has showed 
significantly greater neovasculature in plaques that were enhanced during CEUS 
examination comparing to those that were not (Coli et al, 2008). Visual classification 
of plaque contrast enhancement (none, limited, moderated and significant) has 
showed agreement with the extent of plaque neovascularization (Shah et al, 2007). 
There is ongoing research on methods that would objectively quantify contrast 
enhancement for plaque neovascularization quantification. B-flow imaging technique, 
a method that enhances signal coming from moving ultrasound reflectors and 
visualizes blood flow with high frame rate and resolution, has been used to 
objectively quantify contrast enhancement by the measurement of B-flow image 
thickness (BFI-T). Although BFI-T has been found to be significantly higher in 
patients with atherosclerotic disease, no histological validation for neovascularization 
has been reported yet (Magnoni et al, 2009). 
Another suggested method uses time-signal intensity curve analysis software for 
calculation of the curve of the ultrasound energy reflected by tissue and microbubbles 
over time. Plaque enhanced intensity was calculated by subtracting the baseline 
plaque intensity (i.e. before injection of contrast agent) from the plaque peak intensity 
during contrast enhancement. The ratio of plaque enhanced intensity over the lumen 
enhanced intensity was also calculated. Results indicated significantly greater contrast 
enhancement for symptomatic patients, but no comparison with histological data was 
performed for correlation with angiogenesis (Xiong et al, 2009). Another group 
suggested a similar enhancement quantification method for the calculation of the 
maximum level of plaque dB-Enhanced at the peak contrast agent‟s concentration and 
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reported significantly higher dB-Enhancement in plaques with greater neovessel 
density, as detected using CD34 immunostaining (Faggioli et al, 2011). 
As far as the standard ultrasound ability to assess carotid plaque neovascularization is 
concerned, in a study very recently published, Feinstein‟s group in Chicago compared 
standard duplex ultrasound plaque assessment for echogenicity and degree of stenosis 
with neovascularization identified using CEUS. Results indicate inverse correlation 
for plaque echogenicity and good correlation for degree of stenosis with plaque 
neovascularization. No histological confirmation of neovascularization was performed 
as angiogenesis was decided solely upon CEUS examination (Staub et al, 2011). 
4.7 Plaque inflammation 
Lately there has been increasing interest in establishing techniques for imaging 
atherosclerotic plaque inflammation. Contrast enhanced ultrasound is one of the 
modalities that have showed satisfying results, along with magnetic resonance 
imaging, positron emission tomography and thermography.  
In vitro studies have shown that microbubble contrast agents are phagocytosed by 
macrophages and remain active, reflecting ultrasound beam for up to 30 minutes later. 
In vivo studies have also shown sufficient detection of microbubbles in carotid 
plaques 6 minutes after injection, reporting significant difference in image 
enhancement between symptomatic and asymptomatic patients (Owen et al, 2010). 
Despite the fact that the mechanism of microbubble adhesion to the atherosclerotic 
plaque as well as whether it is inflammation-specific with histological validation 
remains unclear, contrast enhanced ultrasound is a promising modality on plaque 
inflammation assessment.  
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Chapter V 
Carotid plaque size assessment with Ultrasound using 
B-mode measurement methods 
Introduction 
Since the introduction of duplex ultrasound in clinical practice for the assessment of 
carotid atherosclerotic disease, velocity criteria have been used to calculate the degree 
of the stenosis. However, the variety of velocity criteria used nowadays in vascular 
laboratories across the world as well as the fact that velocity measurement remains an 
indirect way to estimate stenosis based on its haemodynamic effects, has urged 
societies of vascular scientists to come up with a universal method of accurate 
calculation of carotid stenosis using duplex ultrasound. 
A method which has been used in a few vascular laboratories alongside the velocity 
parameters as well as in several studies looking on carotid stenosis is the direct 
measurement of the stenosis in internal carotid artery. However, there is no consensus 
yet regarding direct measurement methods accuracy or which among the suggested 
methods should be used when appropriate. 
Using current velocity criteria employed in most vascular laboratories in UK for 
carotid atherosclerotic assessment with duplex ultrasound as reference, methods of 
direct diameter and area measurement applied in ultrasound were investigated for 
agreement and correlation for carotid stenosis calculation. Their accuracy on stenosis 
classification in categories was also investigated in reference to current velocity 
criteria. Lastly, magnetic resonance angiography stenosis measurement was compared 
with direct measurement ultrasound measurements.  
100 
 
Method and materials 
5.1 Selection of patients 
Patients presenting at the vascular clinic, at Hammersmith Hospital, over a period of 
12 months, from February 2008 to February 2009, had a duplex ultrasound scan with 
the investigation protocol for assessing carotid artery disease. The indications for 
carotid investigation were either symptomatic carotid disease, such as prior TIA or 
stroke, or asymptomatic patients with peripheral arterial disease or coronary artery 
disease. The study was approved from the local research ethics committee. 
5.2 Patient assessment 
Patients were interviewed before the scan and a full patient history was taken, 
including: 
a. Current medical condition 
b. Previous vascular or cardiovascular surgeries 
c. Current medication 
d. Presence of any risk factors for cerebrovascular disease described in chapter II 
(smoking, hypertension, diabetes, peripheral vascular disease, coronary artery disease, 
family history of arterial disease) 
e. Presence of any symptoms for cerebrovascular disease described in chapter II 
(aphasia, dysphasia, visual disturbances, vertigo, carotid bruits, dysarthria, weakness 
or paralysis of extremities) 
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Furthermore laboratory results were gathered from patient notes, mainly about risk 
factors associated with atherosclerosis, including levels of: 
a. Cholesterol 
b. Lipoproteins (HDL, LDL) 
c. Triglyceride 
d. Hs-CRP 
e. Fibrinogen 
f. Homocysteine 
5.3 Duplex Ultrasound investigation 
5.3.1 Instrumentation 
For the carotid scanning an HDI ATL 5000 scanner was used, with a linear transducer 
of 5–12 MHz. All images were stored on CD and then transferred and processed in an 
in-lab PC. For diameter and area measurements the software ImageJ (National 
Institute of Health, Maryland, USA), a public domain Java-based image processing 
and analysis software, was used. 
5.3.2 Investigation protocol 
Patients were examined lying supine and carotid arteries were scanned both 
longitudinally and transversely. After the identification of basic landmarks, like the 
common carotid artery (CCA), the carotid bifurcation, the bulb and the internal 
carotid artery (ICA), any atherosclerosis or other pathology present was noted. 
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Maximum peak systolic (PSV) and end diastolic velocities (EDV) in the CCA were 
measured, as well as the intima-media thickness, preferably 20mm below the 
bifurcation (Fig 3.1, point A). In the ICA and ECA the diameter of the vessel (wall-to-
wall) and the minimum residual lumen perpendicular to the longitudinal axis of the 
vessel at the position of maximum constriction, the maximum peak systolic and end 
diastolic velocities in that point, as well as the arterial cross-sectional area of the 
vessel and the residual lumen in the transverse axis were measured (Fig 5.1, point B 
and C). Peak systolic velocity and end diastolic velocity, lumen diameter and area in a 
non-diseased part of ICA distally to the stenosis were also measured (Fig 5.1, point 
D). For all the Doppler investigations and measurements of the flow small sample 
gate at centre steam position was used, in the longitudinal axis of the vessel, at an 
angle preferably at 60
o
 or less. 
 
Fig 5.1, Points of measuring velocity and B-mode data 
5.4 Data processing and analysis 
5.4.1 Haemodynamic parameters 
Flow velocity parameters were calculated, including ICA peak systolic velocity, ICA 
end diastolic velocity, peak systolic velocity ratio (PSVR, maximum peak systolic 
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velocity within constriction in internal carotid artery over maximum peak systolic 
velocity in common carotid artery measured at set distance from bifurcation), peak 
systolic velocity ratio ic/icd (PSVICDR, maximum peak systolic velocity within 
constriction in internal carotid artery over maximum peak systolic velocity in distal 
internal carotid artery) and St. Mary‟s ratio (StM R, maximum peak systolic velocity 
within constriction in internal carotid artery over end diastolic velocity in common 
carotid artery) (Table 5.1). 
 
PSV R Peak systolic velocity ratio ICA/CCA PSVic/PSVcc 
PSVICDR Peak systolic velocity ratio ICA/ICA distally) PSVic/PSVicd 
StM R Peak systolic velocity ICA/End diastolic velocity CCA PSVic/EDVcc 
 
Table 5.1, Velocity parameters calculated. PSVic: PSV within constriction in ICA, PSVcc: 
PSV in CCA, PSVicd: PSV in distal ICA, EDVcc:  EDV in CCA 
 
5.4.2 B-mode parameters 
Using diameter and area measurements in different points of CCA and ICA, diameter 
reduction was calculated using NASCET, ECST and CCA methods (Table 5.2, Fig. 
5.2). Area reduction at the point of maximum constriction in ICA was also calculated. 
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% DST-C Diameter reduction comparing diameter in CCA (Dcc-Dmr)/Dcc x 100 
% DST-N Diameter reduction with NASCET method (Dicd-Dmr)/Dicd x 100 
% DST-E Diameter reduction with ECST method (Dv-Dmr)/Dv x 100 
% AST Area reduction (Av-Amr)/Av x 100 
 
Table 5.2, B-mode parameters calculated. Dcc: diameter in CCA, Dmr: diameter of minimum 
residual lumen, Dv: diameter of vessel, Dicd: diameter of lumen in distal ICA, Av: area of 
vessel, Amr: area of minimum residual lumen 
 
Fig 5.2, Schematic drawing depicting NASCET, ECST and CC methods for angiographic 
assessment of carotid stenosis (Staikov et al., 2002). DST-N: (A-b)/A x100; DST-E: (C-b)/C x 
100; DST-C: (D-b)/D x 100 
5.4.3 Statistic analysis 
The data were processed and analysed using Microsoft Excel (Microsoft, Washington, 
USA) and the statistical software SPSS v19 (IBM, New York, USA). The level of 
significance was set at p < 0.05. Correlations coefficients were used to compare 
different method‟s results. Also t-tests and nonparametric tests were obtained for 
comparison tables.  
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Results 
5.5 Descriptive statistics 
In total 87 patients were scanned and images were taken from both carotids of each 
patient. Therefore 174 cases were analyzed. 
The mean age of patients was 70.9 ± 9.3 years. Sixty six (75.9%) patients were men 
(mean age 70.6 ± 8.6 years) and 21 (24.1%) were women (mean age 71.6 ± 11.3 
years).  Forty five (54.7%) patients were current or past smokers, 65 (74%) suffered 
from hypertension and were treated with medication, 35 (30%) were diabetic, 51 
(59%) had hypercholesterolemia, 47 (54%) had family history of cardiovascular 
disease, 13 (15%) had history of ischaemic heart disease and 10 (11%) had history of 
atrial fibrillation. The mean body mass index was 26.2 ± 4.3 for men and 28.7 ± 7.8 
for women. 
Among the enrolled patients, 52 (60%) had suffered an ischaemic stroke, 19 (22%) 
had suffered a transient ischaemic attack and 16 (18%) reported other cardiovascular 
but not cerebrovascular symptoms in the past. 
The mean internal carotid artery stenosis measured in B-mode using ECST method 
was 39.2% ± 19.2 and the mean internal carotid artery area stenosis was 39.6% ± 
21.7. 
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5.6 Statistic analysis 
5.6.1 Normal distribution 
Velocity and B-mode parameters were tested for normal distribution using 
Kolmogorov-Smirnov test for the whole sample. Diameter stenosis parameters using 
NASCET, ECST and CCA method were found to be normally distributed, while the 
area stenosis and the velocity parameters did not show normal distribution. Below the 
Q-Q plots for the B-mode diameter and area stenosis parameters are sited (Fig 5.3). 
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Fig 5.3, Normal Q-Q Plots of area stenosis and diameter stenosis using NASCET, ECST and 
CCA methods of direct measuring in duplex ultrasound 
5.6.2 Direct diameter and area measurements 
5.6.2.1 Correlation with velocity parameters  
Spearman‟s rank correlation coefficient was used for investigating the correlation 
between PSV in internal carotid artery and direct diameter and area measurement 
using the methods previously described. Test results indicated good correlation (p 
value <0.01) for all direct measurement methods, among which the ECST method of 
diameter measurement showed the highest correlation (correlation coefficient .645, 
p<0.01) (Fig 5.4).  
The good correlation between systolic velocity and direct stenosis measurement is 
explained by the principle of continuity of incompressible fluid motion. According to 
this principle a fluid‟s volume flow rate (i.e. the volume of fluid that passes through a 
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tube per second) is constant and thus fluid velocity is higher in points of tube with 
smaller cross-sectional area. However, it is noteworthy that the ECST method of 
diameter measurement appears to express more accurately this flow velocity and 
vessel diameter correlation. 
 
Fig 5.4, Spearman’s correlation coefficient between different methods for direct diameter and 
area measurement in duplex ultrasound and PSV at internal carotid artery 
5.6.2.2 Classification of stenosis in three categories 
Vascular scientists usually stratify carotid atherosclerotic disease in categories for 
various degrees of stenosis. As mentioned previously, several velocity criteria are 
used to categorize carotid stenosis and this variation has contributed to the confusion 
there is among vascular laboratories and surgeons. The most commonly used velocity 
criteria across UK are Grant et al criteria, named also Consensus of Radiology 
velocity criteria, which were introduced in 2003. Using these criteria, PSV is mainly 
used to grade carotid stenosis in three categories, less than 50%, between 50% and 
69% and greater than 70%. Using the consensus criteria for carotid stenosis 
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classification, direct measurement methods (diameter and area) were investigated for 
agreement with the established PSV method. 
Spearman‟s rho was used to investigate the relationship and correlation between 
stenosis classification results using PSV and Grant et al criteria and direct 
measurement methods. Good correlation was reported for all three methods of 
diameter measurement and the area measurement method (p value <0.05). The 
correlation coefficient was notable greater for area measurement and ECST method of 
diameter measurement. Similar results were produced when the classification using 
direct measurement methods was compared with classification using the Peek Systolic 
Velocity Ratio (PSVR) method of Grant et al criteria. The following graph shows the 
correlation coefficients of all four methods comparing with PSV and PSVR Grant et 
al criteria (Fig 5.5). 
 
Fig 5.5, Spearman’s correlation coefficient between classification of stenosis in three 
categories (<50%, 50-69%, >70%) using different methods for direct diameter and area 
measurement in duplex ultrasound and Grant et al criteria 
Chi test were used to investigate the significance of relationship between the stenosis 
classification calculated using direct diameter and area measurement methods and the 
classification derived by the application of Grant et al velocity criteria. Results 
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indicated significant relationship between classification calculated by PSV criteria 
and direct stenosis measurement classification, reporting a greater Pearson chi square 
value for ECST method and a lower for NASCET method (Table 5.3). 
Method Value Sig. (p value) 
NASCET diameter 14258 0.007 
ECST diameter 84296 0.000 
CCA diameter 60661 0.000 
Area 62246 0.000 
Table 5.3, Chi square test results for classification of stenosis in three categories using PSV 
Grant et al criteria and direct diameter and area methods 
Sign Test reported no significant difference between overestimation and 
underestimation of grading in ECST, CCA and area methods comparing with PSV 
Grant et al criteria, whereas NASCET criteria underestimated 28% of the investigated 
cases. Agreement with PSV criteria was higher for area measurement and lower for 
NASCET diameter method (Table 5.4, Fig 5.6). 
 
Method Percentage of cases 
NASCET 70.1 
ECST 77.0 
CCA 74.6 
Area 80.4 
 
Table 5.4, Percentage of cases classified in the same category using direct diameter and area 
measurement methods and Grant et al velocity criteria 
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Fig 5.6, Percentage of cases tied, overestimated and underestimated using direct diameter 
and area methods comparing with classification of the stenosis using PSVR Grant et al 
criteria 
The agreement of stenosis classification using direct diameter and area measurement 
methods with the classification using Grant et al velocity criteria was investigated 
using Gamma test. NASCET method showed poorer agreement with Grant et al 
classification, whereas ECST and area measurement methods showed greater 
agreement (gamma coefficient was 0.908 and 0.927 respectively) (Fig 5.7). 
 
Fig 5.7, Gamma coefficient for agreement investigation of calculated stenosis using direct 
diameter and area methods and Grant et al velocity criteria 
These results confirm better correlation of ECST and CCA diameter method and area 
measurement method with established velocity criteria used for the classification of 
carotid atherosclerotic disease comparing with NASCET diameter method, which 
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shows great variation and disagreement, mainly because of underestimation of the 
stenosis. 
5.6.2.3 Classification of stenosis in four categories 
Another set of velocity criteria widely used in the literature and applied by some 
vascular laboratories across UK is the Sabeti et al criteria which, contrary to 
consensus criteria, classifies the stenosis in four categories by splitting the lower than 
50% group in two (0-29% and 30-49%). Sabeti et al criteria use mainly the PSV in 
internal carotid artery in addition to the Peek Systolic Velocity Ratio, using different 
cut-off values comparing to Grant et al criteria. 
Carotid artery stenosis calculated by direct diameter and area methods were classified 
in four groups (0-29%, 30-49%, 50-69% and >70%) and the results were tested for 
correlation with classification using Sabeti et al velocity criteria using Spearman‟s rho 
(Fig 5.8). Test reported high positive correlation between classification results (p 
<0.01 for all methods). Among B-mode measurement methods, ECST diameter 
measurement method had a greater correlation coefficient comparing to velocity 
criteria with both PSV and PSVR (0.655 and 0.636 respectively), while NASCET 
diameter measurement method had the lowest (0.605 and 0.524 respectively). 
Chi test was used for investigation of the significance of relationship between the 
stenosis classification in four categories using direct diameter and area measurement 
methods and the classification by applying the Sabeti et al velocity criteria. 
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Fig 5.8, Spearman’s correlation coefficient between classification of stenosis in four 
categories (0-29%, 30-49%, 50-69%, >70%) using different methods for direct diameter and 
area measurement in duplex ultrasound and Sabeti et al velocity criteria 
Results indicated association between classification using direct measurements and 
Sabeti et al velocity criteria (p value < 0.05) for all four methods. The percentage of 
agreement in stenosis grading was lower comparing to that when stenosis was 
classified in three categories for ECST, CCA and area measurement methods (Table 
5.5). Test results indicated that NASCET diameter method underestimated 25% of the 
investigated cases whereas ECST, CCA and area methods overestimated 38%, 31 % 
and 39% of cases respectively (Fig 5.9). 
 
Fig 5.9, Percentage of cases tied, overestimated and underestimated using direct diameter 
and area methods comparing with classification of the stenosis using PSV Sabeti et al criteria 
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Method Percentage of cases 
NASCET 70.7 
ECST 51.0 
CCA 54.4 
Area 56.7 
Table 5.5, Percentage of cases classified in the same category using direct diameter and area 
measurement methods and PSV Sabeti et al criteria 
The agreement of stenosis classification using direct diameter and area measurement 
methods with the classification using Sabeti et al velocity criteria was investigated by 
calculating the Gamma coefficient. All four direct measurement methods showed 
poorer agreement with Sabeti et al velocity criteria comparing with Grant et al 
velocity criteria apart from NASCET method whose agreement with velocity criteria 
was slightly increased. Area measurement method had again the highest gamma 
coefficient (0.898) and CCA method had the lowest (0.769) (Fig 5.10). 
 
Fig 5.10, Gamma coefficient for agreement of calculated stenosis using direct diameter and 
area methods and Sabeti et al velocity criteria in relation with gamma coefficient for 
agreement using Grant et al velocity criteria 
Summing up, the statistic analysis of the classification data reveals a difference in the 
agreement of velocity criteria and direct measurement methods when stenosis is 
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classified in three and four categories. More specifically, the ECST, CCA and area 
measurement methods showed better agreement with Grant et al velocity criteria in 
three-category classification, as a larger number of cases was overestimated by direct 
measurement methods (or underestimated by velocity criteria methods) when stenosis 
was classified in four categories.  
5.6.2.4 Identification of severe stenosis 
Direct diameter measurement methods were tested for ability to identify greater than 
70% stenosis, comparing with velocity criteria currently used. Fisher‟s exact test was 
used to investigate the significance of relationship between direct measurement 
methods and velocity criteria and gamma values were calculated for investigation of 
the strength of association. 
Fisher‟s exact test indicated significant relationship between Grant et al PSV velocity 
criteria and ECST and CCA diameter measurement methods and area measurement 
methods (p < 0.001), while there was no agreement with results using NASCET 
diameter measurement method (p > 0.05) (Table 5.6). 
 
NASCET ECST CCA Area 
Sig. (p value) 
Fisher’s test 0.911 0.000 0.000 0.000 
Table 5.6, Fisher’s exact test results for identification of greater than 70% stenosis using 
direct diameter and area methods comparing with Grant et al PSV velocity criteria 
Gamma coefficient was higher for area measurement method, followed by ECST 
diameter method. CCA method had the weakest agreement among the three methods 
(Fig 5.11). 
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Fig 5.11, Gamma coefficient for agreement of identification of greater than 70% stenosis 
using direct area and ECST and CCA diameter methods and Grant et al PSV velocity criteria 
As far as the sensitivity and specificity is concerned, using Grant et al velocity criteria 
as reference, area measurement method appeared to have the highest sensitivity 
(87.5%) and NASCET diameter measurement method the highest specificity (99%). 
ECST method had the highest positive predictive value (69.2%) and area 
measurement the highest negative predictive value (98.8%) (Fig. 5.12). 
 
Fig 5.12, Sensitivity, specificity, positive predictive value and negative predictive value of 
direct measurement methods for identifying greater than 70% stenosis using Grant et al PSV 
velocity criteria as reference 
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The same statistical analysis was performed comparing identification of greater than 
70% stenosis using direct measurement parameters and the combination of PSV and 
PSVR Grant et al criteria. Velocity ratios are used in cases where PSV itself does not 
correspond, according to the operator, to the stenosis visualized, so as a stenosis 
would be considered severe only if it fulfills both PSV and PSVR Grant et al criteria. 
Fisher‟s test results were same as previously, indicating significant relationship 
between Grant et al velocity criteria and ECST and CCA diameter measurement 
methods and area measurement methods (p < 0.001), while there was no agreement 
with results using NASCET diameter measurement method (p > 0.05). Interestingly, 
gamma coefficients for ECST and CCA diameter measurement methods and area 
measurement method were increased, while sensitivity significantly increased for 
direct diameter methods apart from NASCET. ECST method appeared to have 63.6% 
and area measurement 100%. Specificity remained in high levels and there was a 
slight increase in negative predictive value, being 100% for area measurement and 
96.9% for ECST method (Fig 5.13, Fig 5.14). 
 
Fig 5.13, Gamma coefficient for agreement of identification of greater than 70% stenosis 
using direct diameter and area methods and Grant et al PSV and PSVR velocity criteria 
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Fig 5.14, Sensitivity, specificity, positive predictive value and negative predictive value of 
direct measurement methods for identifying greater than 70% stenosis using Grant et al PSV 
and PSVR velocity criteria as reference 
5.6.2.5 Comparison with MRA 
Among the patients enrolled in the study, few had their duplex ultrasound test 
followed by a magnetic resonance angiography, so as the treatment route could be 
decided by their doctor. Due to the fact that MRA was not routinely used for carotid 
atherosclerotic plaque assessment the number of study participants that had an MRA 
was limited (N=8). 
The degree of the stenosis based on velocity criteria and direct diameter and area 
measurement methods was compared with MRA measurement of the stenosis for 
agreement. Despite the small number of data, results could offer some useful 
information about the variation and accuracy of direct diameter measurement methods 
as results were compared with measurements of another modality. 
MRA measurement and duplex ultrasound direct measurement data were normally 
distributed (Shapiro-Wilk test p value > 0.05 for all measurements) and paired sample 
t-test was used for investigation of agreement between estimation of carotid stenosis 
Sensitivity Specificity
Positive 
Predictive 
Value
Negative 
Predictive 
Value
NASCET 0,0% 99,0% 0,0% 94,2%
ECST 63,6% 96,2% 58,3% 96,9%
CCA 54,5% 96,2% 54,5% 96,2%
Area 100,0% 92,3% 41,7% 100,0%
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using the different methods. Test results showed that t-test hypothesis could not be 
rejected and that there was no significant difference between all direct measurements 
and MRA measurements. Because of the small number of data, Wilcoxon Sign Rank 
Test was also performed, which confirmed the statistic insignificance of difference 
(Table 5.7). 
 NASCET ECST CCA Area 
Paired sample t-test .089 .280 .545 .596 
Wilcoxon test .109 .465 .465 .465 
 
Table 5.7, Paired sample t-test and Wilcoxon Sign Rank Test p value for carotid stenosis 
calculation using direct diameter and area measurement methods compared with MRA 
stenosis calculation 
It is noteworthy however that the p value of both tests in NASCET method was 
considerably lower comparing to the p value of the other methods. 
The deviation of the measured stenosis for each method from the MRA estimated 
stenosis was calculated and the means were compared. NASCET method showed a 
considerably higher mean deviation compared with the rest (28.7% with maximum of 
47% underestimation) while ECST method measurement deviated only by 4.5 % 
(maximum 9% underestimation) (Fig 5.15). These results indicate a much greater 
agreement between ECST, and secondarily CCA and area, measurements and MRA 
measurements. On the other hand NASCET method appears to significantly 
underestimate the stenosis comparing with MRA measurements. 
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Fig 5.15, Mean deviation (percentage) of calculated carotid stenosis using direct diameter 
and area measurements from the MRA measurement of the stenosis 
5.6.3 Corrected NASCET measurement 
Following the difference in results in the two angiographic trials that used different 
stenosis approach, it was suggested that there was a linear relationship between 
NASCET and ECST measurement results, summarized in the following formula: 
𝑬𝑪𝑺𝑻% = 𝟎. 𝟔 𝒙 𝑵𝑨𝑪𝑺𝑬𝑻% + 𝟒𝟎% 
(Rothwell et al, 1994). 
Using NASCET method measurements, a “corrected NACSET” (corNASCET) 
stenosis measurement was calculated using the formula above, and the agreement 
with ECST method measurement and velocity criteria results was investigated. 
Paired sample t-test rejected significance of difference between the two stenosis 
calculation methods (p value 0.998), confirming that corNASCET can produce results 
similar to ECST measurement. Fisher‟s exact test was performed for investigation of 
agreement between stenosis classification results of the two methods and velocity 
criteria. The relationship of velocity criteria was found statistically significant for both 
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diameter measurement methods. However, the gamma coefficients confirmed the 
stronger agreement of ECST with the velocity criteria comparing with corNASCET 
measurements (Fig 5.16). 
 
Fig 5.16, Gamma coefficient for agreement of calculated stenosis using direct diameter and 
area methods and Grant et al velocity criteria 
ECST method superiority comparing with corrected NASCET measurement was 
confirmed in the accuracy to identify greater than 70% stenosis. Fischer‟s exact test 
indicated significant but moderate relationship between corNASCET measurement 
and velocity criteria comparing to strong relationship for ECST method. Again, 
gamma coefficient was greater for ECST method (0.956) comparing with 
corNASCET‟s (0.937). 
5.6.4 Other statistic results 
5.6.4.1 PSVICA/PSVICD velocity ratio 
Apart from the calculation of PSVICA/PSVCCA ratio (PSVR) and the St. Mary‟s ratio 
(PSVICA/EDVCCA), the ratio of PSV in ICA over the PSV in distal ICA 
(PSVICDR=PSVICA/PSVICD) was calculated for each patient and investigated for 
differences between groups of different carotid stenosis. Interestingly, robust test of 
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equality of means (Welch test) indicated significant difference in PSVICD ratio values 
for patients with <50%, 50%-70% and >70% stenosis (Welch value 4.271, p value 
<0.05) (Table 5.8, Fig 5.17). 
ICA Stenosis Mean Std. Deviation 
<50% 0.942 0.298 
50-69% 1.829 0.757 
>70% 3.357 1.659 
 
Table 5.8, Means and Standard Deviation of PSVICD ratio for groups of different ICA stenosis 
 
Fig 5.17, Boxplot of PSVICD ratio values comparing with degree of ICA stenosis 
ROC curve for PSVICD ratio as well as PSVR and St. Mary‟s ratio was calculated for 
investigation of accuracy for identification of greater than 70% stenosis. Despite the 
fact that the area under the curve for PSVICD was the lowest among the velocity ratios 
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(0.891), it represented very good accuracy as a diagnostic test. A PSVICD ratio value 
of 2.0 indicated 80% sensitivity and 91% specificity for identifying greater than 70% 
stenosis, which is comparable with the accuracy of the other two ratios used in 
velocity criteria today (Fig 5.18). In less than 70% stenosis, ratio‟s accuracy to 
distinguish greater and lower than 50% stenosis was lower; a value of 1.0 showed 
76% sensitivity but only 50% specificity in identifying 50-69% plaques. Nevertheless, 
sensitivity and specificity results were similar with those of the other ratios using the 
suggested thresholds. 
 
Fig 5.18, Sensitivity and specificity for PSVICDR (cut-off value = 2), PSVR (cut-off value = 4) 
and St. Mary’s ratio (cut-off value = 14) for identifying greater than 70% stenosis 
5.6.4.2 Intima-media thickness 
Intima-media thickness is a significant marker for generalized atherosclerosis as well 
as a specific risk factor for cerebrovascular disease. 
Statistical analysis of the study‟s data indicated a significant difference between 
symptomatic and asymptomatic patients, which agrees with literature regarding IMT. 
Sensitivity Specificity
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Mean IMT for symptomatic patients was 0.097 ± .02 cm while for asymptomatic 
patients was 0.079 ± .02 cm (Mann-Whitney U value 902.500, p value < 0.01). 
IMT was significantly higher in current or past smokers (0.093 ± 0.03 cm) comparing 
to no smokers (0.086 ± .03 cm, Mann-Whitney U value 1218.500, p value < 0.05). No 
significant difference was found regarding hypertension or diabetes. 
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Chapter VI 
Investigation of carotid plaque grey scale characteristics 
Introduction 
Since the determination of the characteristics of the vulnerable atherosclerotic plaque, 
identification of the vulnerable plaque has become a major research field for all 
imaging modalities. 
Ultrasound is the main diagnostic tool for assessing carotid plaque size and has also 
been used as a screening method. Although computed tomography and magnetic 
resonance imaging have showed promising results on compositional investigation of 
carotid plaque and more and more research focuses on those modalities, studies have 
shown that ultrasound can also provide useful information on plaque morphology and 
composition. However, no consensus has been reached regarding qualitative and 
quantitative characterization of carotid plaque in routine ultrasound investigation. 
The aim of the project is to investigate ultrasound image texture analysis and 
greyscale level of the carotid plaque, the intima-media and the fibrous cap of the 
plaque and examine association with symptomatology and risk factors, looking into 
the possibility of inclusion of such methods in clinical practice in future protocols. 
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Method and materials 
6.1 Selection of patient 
Patients presenting at the vascular laboratory at Hammersmith Hospital, over a period 
of 6 months, from June 2008 to December 2008, were tested with the investigation 
protocol for assessing the composition of carotid plaque, after having a thorough 
ultrasound scan of the carotid arteries following the standard protocol for the 
investigation of the carotid atherosclerotic disease. The indications for investigation 
were either current symptomatic carotid disease, such as TIA or Stroke, history of 
cerebrovascular symptoms in the past or asymptomatic patients with severe peripheral 
arterial disease or coronary artery disease. The study was approved from the local 
research ethics committee. 
6.2 Patient assessment 
Patients were interviewed before the scan and a full patient history was taken, 
including: 
a. Current medical condition 
b. Previous vascular or cardiovascular surgeries 
c. Current medications 
d. Presence of any risk factors for cerebrovascular disease described in chapter 
II (smoking, hypertension, diabetes, peripheral vascular disease, coronary artery 
disease, family history of arterial disease) 
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e. Presence of any symptoms for cerebrovascular disease described in chapter 
II (aphasia, dysphasia, visual disturbances, vertigo, carotid bruits, dysarthria, 
weakness or paralysis of extremities) 
Furthermore laboratory results were gathered from patient notes, mainly about risk 
factors associated with atherosclerosis, including levels of: 
a. Cholesterol 
b. Lipoproteins (HDL, LDL) 
c. Triglyceride 
d. Hs-CRP 
e. Fibrinogen 
f. Homocysteine 
6.3 Duplex ultrasound investigation 
6.3.1 Instrumentation 
An HDI ATL 5000 scanner was used for the carotid scanning, with a 5–12 MHz linear 
array probe. All images were stored in Compact Discs and then transferred and 
processed in an in-lab PC. For diameter and area measurements the software ImageJ 
(National Institute of Health, Maryland, USA), a public domain Java-based image 
processing and analysis software, was used. For image editing and normalization Adobe 
Photoshop CS 5 for Microsoft Windows (Adobe Systems, California, USA) was used. 
For texture analysis, Adobe Photoshop CS5, Mazda (Institute of Electronics, Technical 
University of Łód, Poland) and Image Pro Plus 6.0 (Media Cybernetics, Maryland, 
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USA) were used. Numeric data were typed into Microsoft Excel Spreadsheets 
(Microsoft, Washington, USA) and the statistical package SPSS v19 (IBM, New 
York, USA) was used for statistical analysis. 
6.3.2 Examination protocol 
The composition assessment scan was performed after a standard carotid ultrasound 
scan for identification and measurement of carotid atherosclerotic disease. Patients 
were examined lying supine and carotid arteries were scanned both longitudinally and 
transversely using the anterolateral projection (positioning the transducer in front of 
the sternocleidomastoid muscle), while the scanner settings returned to machine‟s 
default for cerebrovascular vessels examination (32 Hz, Depth 4cm, TI 0.1, MI 0.7, 
Dynamic Range 60 dB). After the identification of the plaque, depth of image, focus, 
total gain and time gain compensation settings were altered to achieve better 
visualization. If internal carotid artery could not be clearly visualized due to vessel 
calcification or tortuosity, lateral projection (positioning the transducer over 
sternocledomastoid muscle) or posterolateral projection (positioning the transducer 
behind the sternocleidomastoid muscle) were used. 
Consecutive pictures of the carotid bifurcation and the internal carotid artery were 
taken in transverse plane in B-mode, acquired by sliding the transducer from the point 
of the bifurcation up the neck following internal carotid artery until the end of the 
plaque. Pictures were taken every approximately 1 cm, so for each plaque a mean of 4 
images were taken, depending on extend of the plaque. The same procedure was 
repeated using colour Doppler imaging, taking care that the colour box was shortened 
to highlight just the vessel so the best image resolution could be achieved. Finally, a 
short loop video (duration of 3 seconds) was recorded while insonating the plaque and 
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sliding the transducer from the bifurcation level going upwards to the end of the 
plaque. 
Then, transducer was rotated head-to-toes and the plaque was identified in 
longitudinal plane. Depth setting was adjusted so as the whole region of plaque could 
be viewed and images were recorded in B-mode. Transducer was slided and tilted so 
as near and far wall adventitia was imaged in right angles and preferably the artery 
intima could be clearly visualized. In cases where plaque could not be outlined easily, 
Colour Doppler images were recorded for identification of the plaque. Last, images of 
common carotid artery intima-media were recorded in longitudinal plane. 
6.4 Image analysis 
6.4.1 B-mode image normalization 
Since images were recorded using different ultrasound scanner settings for the 
optimal visualization of the arteries and plaque by the operator, for the analysis of the 
images to be comparable and reproducible, images needed to be standardized. Images 
for texture analysis were standardized using a method described in the literature based 
on grey scale value of point references, which has shown good reproducibility 
(Elatrozy et al, 1998b). 
After images were transferred to a personal computer, Adobe Photoshop CS 5, an 
image editing software, was used to normalize the images. In the original image, the 
grey scale median (GSM) of two reference areas, blood and artery adventitia, was 
calculated using the histogram function of the software. Then the Curves function was 
used to algebraic linear scale the grey scale of the whole image so as the resulting 
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blood GSM would be between 0 and 5 and adventitia GSM would be between 185 
and 195 (Fig 6.1). The new image was saved in the same format for further analysis. 
 
Fig 6.1, An example of B-mode image normalization by algebraic linear scaling using Adobe 
Photoshop curves. The left image is the original one of a plaque in internal carotid artery. 
The right image is the resulted one, after the linear scale using curves function (central 
image). The black arrows indicate the grey scale values of reference point 
 
6.4.2 Intima-media grey scale median calculation 
In normalized common carotid artery images, histogram function of Adobe Photoshop 
software was used for calculation of the grey scale median of artery‟s intima-media. 
In all cases, the far vessel wall intima-media was analyzed. While zoomed at the 
vessel wall, a part of intima-media was selected using the Polygonal Lasso Tool. The 
histogram function was then used for calculation of the GSM (Fig 6.2). 
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Fig 6.2, An example of common carotid artery intima-media selection and GSM calculation 
using Adobe Photoshop 
 
6.4.3 Carotid plaque grey scale median calculation 
Using the same technique, carotid plaque‟s grey scale median was calculated. After 
loading the standardized image in Adobe Photoshop, Polygonal Lasso Tool was used 
to select the whole plaque. Both longitudinal and transverse images were used. Grey 
scale median was calculated using the histogram function for all the images (Fig 6.3). 
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Fig 6.3, An example of internal carotid plaque selection and GSM calculation using Adobe 
Photoshop on a colour Doppler greyscale normalized image 
6.4.4 Fibrous cap thickness and GSM 
Using the same technique, carotid plaque fibrous cap‟s grey scale median was 
calculated, using Adobe Photoshop and the Polygonal Lasso Tool. Both longitudinal 
and transverse images were used. Grey scale median was calculating using the 
histogram function for all the images (Fig 6.4). Fibrous cap thickness was measured 
using ImageJ software. 
 
Fig 6.4, An example of fibrous cap selection and GSM calculation using Adobe Photoshop 
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6.4.5 First order grey level parameters calculation 
For the calculation of first order grey level parameters, variance, skewness and 
kurtosis, for the carotid plaque, Mazda software was used. Normalized greyscale 
image was loaded in the software and the polygon draw tool was used for the 
selection of the whole plaque as the region of interest to be analyzed. Then analysis 
was run and results were typed in Microsoft Excel Spreadsheets. In cases where there 
was plaque identified in both near and far artery wall, both regions were selected and 
analyzed (Fig 6.5). 
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Fig 6.5, Examples of internal carotid plaque selection for analysis using Mazda software 
Variance 
Variance is a measure of variability of data and describes their distribution around the 
mean. For univariate data Y1, Y2, ..., YN, variance is defined by the formula: 
 (𝑌𝑖−𝑌 )2𝑁𝑖=1
𝑁
, where 𝑌  is the mean and N is the number of data points. 
Skewness 
Skewness is a measure of asymmetry from the normal distribution. It can come in the 
form of positive or negative skewness, depending on whether the data are skewed to 
the right or to the left of the data average. For univariate data Y1, Y2, ..., YN, skewness 
is defined by the formula: 
 (𝑌𝑖−𝑌 )3𝑁𝑖=1
(𝑁−1)𝑠3
, where 𝑌  is the mean, s is the standard 
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deviation and N is the number of data points. Skewness is zero in normal distribution 
and near zero in symmetric data. 
Kurtosis 
Kurtosis is a measure of whether data are peaked or flat comparing to normal 
distribution. Positive kurtosis means data tend to have a sharp peak near the mean, 
whereas negative kurtosis data tend to have a flat top. For univariate data Y1, Y2, ..., 
YN, kurtosis is defined by the formula: 
 (𝑌𝑖−𝑌 )4𝑁𝑖=1
(𝑁−1)𝑠4
−  3, where 𝑌  is the mean, 
s is the standard deviation and N is the number of data points. 
6.4.6 Percentiles calculation 
Using Image Pro Plus 6.0 software, the percentage of pixels (percentiles) with grey 
scale value lower than 20 (P20), 25 (P25), 30 (P30), 35 (P35) and 40 (P40) were 
calculated in normalized grey scale ultrasound pictures of plaques. 
Plaque area was selected using Adobe Photoshop as described previously (6.4.3) and 
a new image, containing only the plaque, was loaded in Image Pro Plus. A macro was 
created that used Count/Size function and Histogram based selection for identification 
and calculation of percentage of area with grey scale value ranging 0-25, 0-30, 0-35 
and 0-40 (Fig 6.6). 
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Fig 6.6, Example of plaque selection and percentile calculation using Image Pro Plus 
 
6.5 Subjective plaque classification 
Cases were classified subjectively using standardized images as far as echogenicity 
(echogenic or echolucent), homogeneity (homogeneous or heterogeneous) and 
morphology (regular or irregular) is concerned. 
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Results 
6.6 Descriptive statistics 
In total, 40 patients were scanned and images were taken from both carotids of each 
patient. Therefore 80 cases were analyzed. 
The mean age of patients was 68.7 ± 9.2 years. Twenty nine (72.5%) patients were 
men (mean age 69.5 ± 8.5 years) and 11 (27.5%) were women (mean age 66.64 ± 
11.0 years).  Thirteen (32.5%) patients were current or past smokers, 32 (80%) 
knew to have hypertension and were treated with medication, 13 (32.5%) were 
diabetic, 20 (50%) had hypercholesterolemia, 8 (20%) had history of ischaemic heart 
disease and 5 (17.5%) had history of atrial fibrillation. 
Among the enrolled patients, 34 (85%) had a recent cerebrovascular event (stroke or 
transient ischaemic attack and 6 reported other recent cardiovascular symptoms or 
cerebrovascular-like symptoms (vertigo etc). 
Thirty two cases with no or minimal carotid stenosis were excluded from further 
analysis. In 8 cases marked carotid stenosis was identified using velocity criteria and 
no good B-mode image of the plaque could be recorded due to technical difficulties 
and were excluded from the study. From forty cases that were further analyzed, 4 
cases had greater than 70% stenosis, 6 cases had 50% to 69% stenosis and 30 cases 
had 20-49% stenosis. 
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6.7 Statistic analysis 
6.7.1 Normal distribution 
Image texture analysis grey level parameters were tested for normal distribution using 
Shapiro-Wilk test. Common carotid intima-media GSM, GSM of plaque‟s fibrous cap 
in short axis, mean plaque GSM from long and short axis views, plaque GSM in best 
view (long or short axis view) and grey scale values standard deviation in best (long 
or short axis) view, Variance in long and short axis, Skewness in long and short axis 
and in best view were reported to be normally distributed (Table 6.1). Kurtosis in long 
or short axis, mean grey scale values standard deviation from long and short axis 
views, and fibrous cap GSM in long axis view reported no normal distribution . 
 
Parameter Sig. (p value) Parameter Sig. (p 
value) 
Common Carotid Artery 
Intima-media GSM 
.966 Grey scale value 
standard deviation in 
best view 
.095 
Fibrous Cap GSM Short 
axis 
.392 Variance in best view 0.001 
Fibrous Cap GSM Long 
axis 
.004 Skewness in best view .048 
Mean plaque GSM (long & 
short axis) 
.246 Kurtosis in best view 0.000 
Plaque GSM in best view .072 Mean grey scale value 
standard deviation in 
long and short axis 
.022 
 
Table 6.1, Shapiro-Wilk test p-values for normality of distribution of image texture analysis 
grey level parameters 
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6.7.2 Common carotid intima-media GSM 
The grey scale median of the intima and media layers of common carotid artery far 
wall was compared with internal carotid artery plaque grey scale median (long and 
short axis mean GSM and GSM in best view) for correlation using Pearson‟s 
Correlation test since all parameters were normally distributed. Test indicated no 
significant correlation between parameters (p value > 0.05). 
Common carotid intima-media GSM was compared for difference between cases with 
internal carotid plaque with high or low GSM value, using 32 as a cut-off point. The 
parameter was distributed normally in the two groups (Shapiro-Wilk test p value > 
0.05) and t-test was used for investigation of difference‟s significance. Despite the 
fact that common carotid intima-media GSM was reported to be slightly higher in 
cases with more echogenic plaque (Fig 6.7), there was important overlap and the 
difference was found insignificant according to t-test results (p value > 0.05) 
 
Fig 6.7, Boxplot of common carotid intima-media GSM in patients with internal carotid 
plaque with GSM less or greater than 32 
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Common carotid intima-media GSM was then investigated for difference between 
cases with severe (greater than 70% of diameter stenosis using ECST method) and 
milder stenosis (less than 70% of diameter stenosis) in internal carotid artery. 
Parameter was normally distributed in the two groups (Shapiro-Wilk test p value > 
0.05) and t-test was used for significance examination. The GSM of common carotid 
intima-media was found to be less in patients with severe stenosis (mean GSM 27.7 ± 
5, N=5) comparing with patients with less than 70% stenosis (mean GSM 40.68 ± 13, 
N=53) (Fig 6.8). However, t-test was marginally negative for statistical significance 
of that difference (p value 0.095, equal variances assumed). 
 
Fig 6.8, Boxplot of common carotid intima-media GSM in patients with severe (>70%) or 
milder (<70%) internal carotid artery stenosis based on ECST method diameter measurement 
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There was no difference found in common carotid artery intima-media GSM between 
symptomatic or asymptomatic patients (t-test p value > 0.05). However, significantly 
lower GSM values were reported in patients with high blood cholesterol levels (mean 
35.2 ± 13.5) comparing with patients with normal blood cholesterol levels (mean 43.5 
± 13.3, Mann-Whitney U 324.5, p < 0.05) (Fig 6.9). 
 
Fig 6.9, Boxplot of common carotid intima-media GSM in patients with high and low/normal 
blood cholesterol levels 
No correlation was reported between common carotid intima-media GSM and other 
cardiovascular risk factors. 
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6.7.3 Plaque texture analysis and subjective classification 
Carotid plaque subjective classification concerning echogenicity and homogeneity 
was compared with computerized texture analysis results. 
6.7.3.1 Echogenicity 
Among the parameters investigated for difference in plaques classified subjectively as 
echogenic and echolucent, grey scale median of the plaque in all views separately and 
the mean grey scale median of the plaque as well as variance in best view were found 
to be statistically different between groups (Table 6.2, Fig 6.10). Parameters were 
normally distributed in two groups (Shapiro-Wilk test p value > 0.05) and therefore t-
test was used for investigation of difference significance. 
 Echolucent Echogenic Sig. (p value) 
Mean plaque GSM 16.1 ± 12.8 54.8 ± 20.1 0.000 
Plaque GSM in best view 16.3 ± 5.7 54.7 ± 23.9 0.000 
Plaque GSM in short axis 13.6 ± 13.4 57.5 ± 18.5 0.000 
Plaque GSM in long axis 16.8 ± 11.5 53.5 ± 22.1 0.000 
Variance 664.2 ± 318.2 1480.3 ± 845.8 0.005 
Table 6.2, Mean values and t-test results for grey scale parameters for echolucent and 
echogenic plaques 
ROC curves were calculated for mean plaque GSM for identification of echolucent 
plaque. Results indicate that GSM value of 35 had 100% sensitivity and 72.2% 
specificity in echolucent plaque identification. The area under the curve was 0.954. 
Similar were the results from the ROC curve calculation for plaque GSM in best 
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view. For GSM value of 32, sensitivity was 100% and specificity was 72 %, with the 
area under the curve being 0.931. Both plaque GSM measurements reported excellent 
accuracy for separating the two groups. 
 
Fig. 6.10, Boxplot of plaque variance in echogenic and echolucent plaques as they were 
classified visually 
ROC curve was calculated for plaque variance for investigation of ability to 
distinguish echolucent plaque. The area under the curve was 0.833 which stands for 
good accuracy and a variance threshold of 830 showed 83% sensitivity and 71% 
specificity for identifying echolucent plaques. 
Rest of the parameters that were significantly different in echogenic and echolucent 
plaques showed a smaller under the curve area. 
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6.7.3.2 Homogeneity 
Among the parameters investigated for difference in plaques classified subjectively as 
homogeneous or heterogeneous, grey scale value standard deviation seemed to have 
different values in the two groups (Fig 6.11); homogeneous plaques had a mean grey 
scale value standard deviation of 28.9 ± 10.0, lower than that of heterogeneous 
plaques which had a mean value of 37.8 ± 10.7. Parameter showed normal 
distribution in both groups (Shapiro-Wilk test p value > 0.05) and t-test was used for 
investigation of significance. Test results were marginally negative for significance of 
the difference (p = 0.064, equal variances not assumed). 
 
Fig 6.11, Boxplot of grey scale value standard deviation in best view (long or short axis) in 
homogeneous and heterogeneous plaques as they were classified subjectively 
ROC curve was calculated for grey scale value standard deviation in best view so the 
ability of this parameter to identify heterogeneous plaques could be investigated. Area 
under the curve was 0.741, indicating fair accuracy for group separation. A standard 
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deviation value of 30.4 reported a sensitivity of 77.8% and specificity of 66.6% for 
identifying heterogeneous plaque. 
6.7.4 Plaque GSM and degree of stenosis 
Plaque GSM was investigated for difference in patients with different degree of 
internal carotid artery stenosis. Plaques causing greater stenosis had lower GSM in 
best view than plaques causing milder stenosis (Table 6.3, Fig 6.12). It was normally 
distributed in all three groups (Shapiro-Wilk test p value > 0.05) and ANOVA test 
was used for examination of difference significance. Test results indicated no 
significance in the difference of plaque grey scale median among the groups (Table 
6.4). 
 
Degree of stenosis Plaque grey scale median 
<50% 50.5 ± 25 
50-69% 34.0 ± 17 
>70% 18.0 ± 8 
 
Table 6.3, Plaque GSM in best view mean values in patients with different degree of stenosis 
measured using ECST diameter measurement method 
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Fig 6.12, Boxplot of plaque GSM in best view mean values in patients with different degree of 
stenosis measured using ECST diameter measurement method 
Groups of patients according 
to degree of stenosis 
Mean 
difference 
Std Error Sig. (p value) 
< 50% 
50-69% 16.5 10.9 0.306 
>70% 32.5 14.2 0.081 
50-69% 
< 50% -16.5 10.9 0.306 
>70% 16.0 15.9 0.583 
>70% 
< 50% -32.5 14.2 0.081 
50-69% -16.0 15.9 0.583 
 
Table 6.4, ANOVA test results for plaque grey scale median in groups patients with <50%, 
50-69% and >70% stenosis 
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6.7.5 Grey scale percentiles 
The percentage of plaque area (percentiles) with grey scale value ranging from 0 up to 
particular cut-off values were compared between symptomatic and asymptomatic 
patients for investigation of difference. Indeed, all five percentiles were lower in 
plaques from symptomatic patients comparing to those from asymptomatic patients 
(Table 6.5, Fig 6.13). 
Percentiles were normally distributed for both symptomatic and asymptomatic 
patients (Shapiro-Wilk test p value > 0.05) and t-test was used for investigation of 
significance of difference. 
T-test results indicated significant difference for all percentiles between symptomatic 
and asymptomatic patients, with p value ranging from 0.003 to 0.034 
 
 Symptomatic Asymptomatic Sig. (p value) 
P20 41.90 ± 21.0 22.44 ± 22.9 0.034 
P25 49.21 ± 21.1 27.77 ± 24.1 0.022 
P30 55.55 ± 20.4 33.22 ± 25.5 0.017 
P35 61.17 ± 19.6 38.07 ± 25.4 0.012 
P40 66.27 ± 18.2 42.50 ± 24.9 0.007 
 
Table 6.5, Percentile mean values and standard deviation for symptomatic and asymptomatic 
patients and t-test p value for significance of difference 
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Fig 6.13, Boxplot of P40 for symptomatic and asymptomatic plaques 
ROC curves were calculated for Percentiles for investigation of accuracy in 
identifying symptomatic plaques. P40 and P35 had the greatest area under the curve 
(0.768) and P20 had the smallest (0.745), which describes fair diagnostic accuracy. A 
P40 value of 50, which is interpreted as 50% of plaque pixels having grey scale value 
less than 40 in a 0 to 256 grey tones scale, had a sensitivity of 80% and specificity of 
75% for identifying potentially symptomatic plaque. 
6.7.6 Fibrous cap investigation 
Plaques of patients with cerebrovascular symptomatology had a significantly thinner 
fibrous cap comparing to asymptomatic patients (Fig 6.14). Mean fibrous cap 
thickness for symptomatic patients was 0.29 ± 0.05 mm while in asymptomatic 
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patients it was 0.38 ± 0.08 mm and t-test confirmed statistical significance of this 
difference between the groups (t-test p value < 0.05 with equal variances). No 
difference was found between patients with a history of stroke and patients with 
history of TIA. 
 
Fig 6.14, Boxplot of fibrous cap thickness in symptomatic and asymptomatic patients 
Plaque fibrous cap was also found significantly thinner in plaques whose morphology 
was characterized as irregular (Fig 6.15). Plaques with regular morphology had a 
mean fibrous cap thickness of 0.32 ± 0.05 mm while irregular plaques had a mean 
fibrous thickness of 0.26 ± 0.05 mm, a difference which was found statistically 
significant (t-test p value <0.05 with equal variances). 
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Fig 6.15, Boxplot of fibrous cap thickness of regular and irregular plaques 
No association was found between fibrous cap thickness and plaque‟s echogenicity or 
size. As far as cardiovascular risk factors are concerned, fibrous cap was slightly 
thinner in plaques of smokers and diabetic patients but there was overlap and 
difference was found statistically insignificant. 
Regarding fibrous cap GSM, it was well correlated with plaque GSM (Spearman 
coefficient 0.379, p value <0.5) and was slightly higher in irregular plaques and 
plaques causing severe stenosis. However, none of these differences were statistically 
significant. 
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6.7.6 Grey level parameters and symptomatic plaque 
The comparison of plaque Variance, Skewness and Kurtosis between symptomatic 
and asymptomatic patients did not indicate any significant difference between the two 
groups. However, it is noteworthy that asymptomatic plaques had a higher Kurtosis 
value comparing to symptomatic. Particularly, Kurtosis value of less than 0.6 had 
100% specificity in distinguishing symptomatic and asymptomatic plaques. 
Grey scale median was lower in symptomatic patients (mean 40) than asymptomatic 
(mean 49) patients; however there was a considerable overlap and statistical analysis 
rejected significance. 
6.7.7 Image texture analysis and cardiovascular risk 
factors 
Image grey scale parameters results were compared with patient cardiovascular risk 
factors for correlation. Kurtosis of internal carotid plaque was reported having 
significantly lower values in patients that used to be or currently were smokers (mean 
1.03 ± 2.8) comparing with no smokers (mean 2.16 ± 2.2, Mann-Whitney U 41.000, p 
value < 0.05). No other correlation was observed. 
6.8 Combination of plaque ultrasound characteristics 
for estimation of risk for stroke 
Following the statistical analysis of image texture parameters in symptomatic and 
asymptomatic patients, counting in the significance of the degree of stenosis, a 
number of ultrasound characteristics of the carotid plaque were combined in an effort 
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to create a scoring system that would provide information upon plaque vulnerability 
and possibility for symptomatic disease. The variables that were used and the score 
points for each are cited in Table 6.6. Minimum total score for a plaque was 0 and 
maximum score was 6. 
 Score points 
DUS variables 0 1 2 
Percentile 40 (P40) (%) 0-34 35-59 >60 
Diameter stenosis (ECST 
method) (%) 
0-50 50-70 >70 
Fibrous cap thickness (mm) >0.3 <0.3  
Intima-media thickness (cm) <0.11 >0.11  
 
Table 6.6, Duplex ultrasound variables and score points for carotid plaque assessment 
Three categories for risk of stroke were defined; low risk for score 0-1, increased risk 
for score 2-3 and high risk for score 4-6. 
 
Table 6.7, Score system risk stratification  
0-6
Total score
0-1
Low risk
2-3
Increased risk
4-6
High risk
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Distribution of study‟s patients using the proposed score indicated that almost 95% of 
symptomatic plaques fell within increased or high risk group, while all no 
asymptomatic plaques had a score greater than 3 (Fig 6.16). 
The odds ratio (OR) of symptomatic disease for a plaque that had a total score equal 
to or greater than 3 was 13.714 (95% CI 1.381 to 136.212). The relative risk for 
symptomatic disease for plaques in increased risk comparing with plaques in low risk 
group was 3.93 (p value < 0.05) while the relative risk for plaques in increased or 
high risk comparing with plaques in low risk was 5.5 (p value <0.05). 
The relative risk for each score system component separately was significantly lower 
compared with scoring system relative risk. Particularly, for Fibrous cap thickness 
relative risk was 1.28, for IMT was 1.75, for stenosis greater than 70% was 1.41 and 
for P40 was 1.64. 
 
Fig 6.16, Stratification of symptomatic and asymptomatic plaques in risk groups using the 
proposed scoring system 
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Chapter VII 
Discussion 
7.1 Introduction 
In the last decades, the advances in science and medicine have lead to a better 
understanding of pathophysiology of cardiovascular disease and specifically 
atherosclerosis. Twenty years ago, identification of high cholesterol as a risk factor 
for cardiovascular diseases was a major breakthrough and quickly became the main 
target for both prevention and treatment research. Since then, a number of risk factors 
have been found, many of the mechanisms have been explained, sets of markers for 
predicting risk have been suggested and new ways of investigation and treatment are 
being validated (Fig 7.1). However, despite the advances in knowledge and expertise, 
prevention of cardiovascular disease has not reached its full potential and 
cardiovascular disease remains the leading cause of deaths worldwide. 
 
Fig 7.1, TIME magazine covers illustrating cholesterol and inflammation as risk factors for 
cardiovascular disease and the importance of prevention 
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Today, stroke is a major cause of death and disability, causing in UK around 53,000 
deaths each year and being responsible for approximately 175,000 hospital visits, 
while only in England around 21,000 surgical procedures are stroke related. The 
overall economic cost of cerebrovascular disease goes up to £5 billion, predicted to 
increase in the future due to the ageing population. 
Approximately half of the ischaemic strokes are due to emboli from atherosclerotic 
plaques located in carotid arteries and thus, early diagnosis and accurate investigation 
of carotid atherosclerotic diseases is of great importance for stroke prevention and 
management. Duplex ultrasound is currently the main diagnostic tool for assessment 
of carotid stenosis and treatment decisions as well as patients follow up depend 
predominantly on ultrasound findings. Computed tomography angiography and 
magnetic resonance angiography have also been introduced in carotid stenosis 
investigation with promising results, however in clinical practice they are solely used 
in cases where ultrasound assessment is inconclusive. 
Despite the fact that carotid ultrasound is the mostly used stand-alone imaging 
modality for carotid disease investigation, there is still debate regarding methods and 
criteria for calculating the degree of stenosis as well as techniques for acquiring 
quantitative information about the carotid plaque itself. Ongoing research aims to 
provide answers and standardize techniques and protocols, however the remaining 
confusion leads to the risk of ultrasound being held back with the excuse of 
obsolescence and unreliability, while other techniques are constantly improving and 
new techniques come into practice. 
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7.2 Carotid stenosis measurement 
The degree of stenosis of internal carotid artery by the atherosclerotic plaque has been 
the first and most assessed characteristic of carotid disease and its accurate 
determination is very important for any diagnostic modality, even after the 
identification of additional characteristics which add in plaque vulnerability. 
Velocity criteria are predominantly used for carotid stenosis estimation with 
ultrasound, based on the haemodynamic effects of the stenosis. A number of different 
sets of velocity parameters and criteria have been published and despite the consensus 
recommendations in 2003 which tried to standardize investigation protocol, confusion 
remains in vascular laboratories across European countries, including UK. Recent 
joint recommendations from the Vascular Society and the Society of Vascular 
Technology in Great Britain and Ireland addressed and tried to resolve the issue, 
suggesting the use of velocity criteria and introducing direct diameter measurement in 
case of bulb stenosis in cases of carotid bulb diameter exceeding 10 mm.   Controversy 
still remains on the ability of ultrasound to accurately calculate the stenosis in B-mode 
as well as on the methods for diameter measurement, since suggested velocity criteria 
are based on NASCET method but instead for bulb stenosis measurement the ECST 
method is recommended. 
The inclusion of direct stenosis measurement in the carotid ultrasound protocol 
alongside velocity parameters could potentially increase modality‟s accuracy and 
extend its potentials for assessing the disease. The size of carotid plaque and the 
degree of stenosis need to be accurately measured for patient monitoring in 
consecutive follow-ups in order to note possible disease progress or regress due to 
treatment. For that purpose, classification of stenosis in categories of 20% is barely 
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useful and since haemodynamic parameters can hardly distinguish smaller 
differences, addition of direct measurement could provide more precise stenosis 
determination. Furthermore, velocity parameters cannot accurately assess less than 
50% stenosis because of limited haemodynamic effect. Therefore, most reports 
classify any mild stenosis as a “less than 50%”, regardless if it is 40% or 20%. 
Moreover, direct measurement results remain independent from cardiac function, 
contralateral disease or proximal or distal lesions, factors that have haemodynamic 
impacts and affect velocity parameters. However, there are also limitations for their 
use, like the acoustic shadowing of severe plaque calcification which prevents plaque 
visualization or significant plaque echolucency which makes the plaque hardly visible 
and the size calculation almost impossible. Nevertheless, a combination of velocity 
parameters and direct measurements could counter those limitations and increase the 
accuracy of the investigation protocol. 
Using current velocity criteria used in vascular laboratories across UK as reference, 
different methods of direct stenosis measurement were applied for this study and 
investigated for accuracy. The number and the variety of cases examined allows for 
quite safe conclusions. Both symptomatic and asymptomatic patients were scanned as 
occurs in every vascular laboratory‟s routine practice. 
Among direct diameter measurement methods, ECST method indicated significantly 
better correlation with velocity criteria comparing with CCA and NASCET methods 
(Fig 5.4). Area measurement method also showed very good correlation with velocity 
criteria. These results are in accordance with published findings that suggest 
agreement of ECST and CCA angiographic methods with velocity criteria comparing 
with NASCET method (Staikov et al, 2000). 
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Stenosis grading could not be compared directly since velocity criteria only classify 
the stenosis in categories rather than giving a precise percentage of stenosis, so direct 
stenosis measurement were used for classifying the stenosis and results were 
examined. 
In general, agreement between direct stenosis measurement and velocity criteria was 
greater when the stenosis was graded in three (0-49%, 50-69% and >70%) rather than 
in four (0-29%, 30-49%, 50-69% and >70%) categories (Fig 5.10). In three categories 
classification, the ECST method had the best correlation with velocity criteria 
comparing with the rest, with an agreement that reached 80% of results. It is 
noteworthy that ECST method almost equally underestimated and overestimated 
some cases, whereas NASCET method underestimated 30% of the cases and area 
measurement tended towards overestimation of the stenosis. However, when stenosis 
was classified with different criteria in 4 categories, all methods severely 
overestimated the stenosis except for NASCET which still underestimated it (Fig 5.9). 
These results showed significant disagreement between direct stenosis measurement 
methods and velocity criteria in mild carotid stenosis. Considerable disagreement was 
found in cases of plaques in the bulb, where velocity criteria significantly 
underestimated the stenosis comparing with direct measurement findings (Fig 7.2). 
Keeping in mind that various studies have reported inaccuracy of velocity criteria to 
further classify stenosis less than 50%, the disagreement could be caused by this 
inaccuracy and the false underestimation of the stenosis by velocity criteria rather 
than by false overestimation of direct stenosis measurement methods. Another reason 
for the deviation between stenosis grading with velocity criteria and direct 
measurement methods could be cases of inability to correctly align the probe with the 
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vessel and use a Doppler angle of 45-60
o
 due to technical difficulties (e.g. distal 
bifurcation), in which case the velocity measurements could be incorrect. 
 
 
Fig 7.2, Examples of stenosis underestimation with velocity criteria; in the first picture, a 
plaque in the bulb causes more than 50% stenosis measured with ECST diameter 
measurement method but velocity criteria classifies it as a less than 50% stenosis, even less 
than 30% if Sabeti et al criteria are applied. In the second picture, a plaque in proximal 
internal carotid artery causes approximately 40% of stenosis measured with ECST diameter 
measurement method, however velocity criteria classify it as less than 30% stenosis. In the 
transverse plane the area stenosis of the plaque can be visualized. 
Similar comparison was executed to investigate the ability of the methods to identify 
severe (greater than 70%) stenosis, using current velocity criteria as reference. Among 
the diameter measurement methods, ECST method had the highest sensitivity, 
positive predictive value and negative predictive value, followed closely by CCA 
method. NASCET method reported minimal sensitivity but high specificity (Fig 
5.14). This is explained by the fact that NASCET method severely underestimated 
stenosis, classifying as severe only a fraction of cases with actual severe stenosis. It is 
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noteworthy that area measurement method reported great accuracy in identification of 
severe stenosis. 
In a number of cases, NASCET method resulted in a paradox of negative stenosis, 
because distal disease-free part of internal carotid artery was of smaller caliber than 
the residual lumen of proximal internal carotid artery. This was more common in 
cases of mild stenosis, where lumen was not severely decreased, or in case of 
significant artery remodeling at the point of plaque, in which case the residual lumen 
was larger than the implied stenosis because of the vessel enlargement. This is a 
major limitation for NASCET method which increases the variation of its results and 
explains up to a degree the disagreement with other direct measurement and velocity 
criteria findings. 
Magnetic resonance angiography was also used as reference for direct measurement 
method investigation. Despite the limited number of patients, the agreement with 
ECST diameter measurement method was apparent compared with the rest. The mean 
deviation of ECST diameter measurements from MRA measurements was only 4.5%, 
while NASCET diameter method‟s measurements deviated by 28.7% (Fig 5.15). 
Although MRA is not a gold standard in carotid diseases investigation, it is used in 
case of inconclusive results from ultrasound assessment and the significant agreement 
with ECST method demonstrates the accuracy of the method. Comparison with digital 
subtractive angiography and computed tomography angiography could also provide 
useful information regarding the comparison of ultrasound B-mode measurement 
methods. Furthermore, comparison of B-mode measurement methods with other 
imaging modalities in greater number of patients could allow investigation of their 
accuracy in determining the exact degree of mild and moderate stenosis, since such an 
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investigation cannot be performed using velocity parameters as reference due to their 
low accuracy. 
Retrospective analysis of the angiographic trials that introduced NASCET and ECST 
methods of stenosis measurement suggested that ECST and NASCET results are 
related with a particular formula. Using that formula, a corrected NASCET estimation 
for degree of stenosis was calculated and results were compared with ECST method‟s 
using velocity criteria as reference. The aim was to investigate whether NASCET 
method could be applied in ultrasound and provide a more accurate stenosis 
estimation using the particular formula rather than reporting the initial estimation as 
the degree of stenosis. Although the agreement of corrected NASCET estimation with 
velocity criteria was improved, it remained inferior to ECST method regarding 
grading the stenosis and identifying greater than 70% stenosis. Taking into 
consideration than this would be an indirect and complicated method for stenosis 
calculation, there is no point for such a suggestion, despite the relatively accurate 
results. 
In summary, ECST direct diameter measurement method indicated very good 
agreement with velocity criteria and excellent agreement with magnetic resonance 
angiography in grading stenosis, particularly in cases of moderate and severe stenosis. 
The marked deviation in cases of mild stenosis should be further analyzed but could 
be attributed to the milder haemodynamic effect of this degree of stenosis which 
makes velocity criteria relatively inaccurate. CCA method also showed significant 
agreement with velocity criteria for diameter stenosis calculation, however it was 
inferior compared with ECST in every test. NASCET method showed major 
limitations and the variation of stenosis estimations is prohibitive for ultrasound 
application. Area stenosis could provide useful information in case of discrepancy 
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between velocity and diameter measurement results as it offers a different view of 
stenosis anatomy, but care should be taken in its application as wrong placement of 
the probe could lead to overestimation of the stenosis. 
7.3 Plaque grey scale characteristics 
Following the description of the vulnerable plaque, the plaque which usually results in 
symptomatic disease regardless its size, identification of such plaques using imaging 
modalities has been the aim of much research in the field of stroke management. 
Despite the fact that new modalities such as MRA, CTA and PET have shown 
promising results on plaque characterization, most of them are still used in research 
institutions rather than in clinical practice. Moreover, modern ultrasound scanners 
with higher resolution probes can now provide information about the plaque 
morphological characteristics. Given the fact that duplex ultrasound is the first and 
most of the times the only imaging examination of a carotid plaque, such information 
can prove very useful for the further patient management and risk stratification. 
Plaque echolucency has been associated with soft tissue components, like lipid and 
haemorrhage, as well as with a high risk for symptoms, comparing with increased 
plaque echogenicity. Since its introduction, grey scale median has been investigated 
in a great number of studies but despite its positive results, no thresholds and criteria 
have been established, preventing it from being implemented in routine ultrasound 
carotid assessment protocol. Recently, other measurements, like grey scale percentile 
calculation or fibrous cap thickness, have been studied with mixed results. To date, 
quantitative characterization of the plaque is not included in the standard ultrasound 
carotid investigation procedure. 
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Common carotid intima-media thickness is a well established atherosclerosis marker, 
with particular significance for carotid atherosclerotic disease. Investigating intima-
media grey scale characteristics, intima-media GSM showed an association with 
plaque GSM, as mean intima-media GSM was higher in plaques of high echogenicity, 
however the difference was not found significant in this study (Fig 6.6). In a recent 
much larger study conducted in Uppsala, Sweden, which enrolled more than 1,000 
patients, a good correlation between plaque and intima-media GSM was reported 
(Lind et al, 2007). Such an association seems logical, since deposition of lipoproteins, 
which is a major factor for plaque echogenicity, occurs along the whole artery and is 
responsible for intima-media thickening and plaques forming in other points of 
arterial network. This is confirmed by the significantly lower intima-media GSM 
found in patients with high blood cholesterol levels (Fig 6.8). Recent studies have also 
reported association of intima-media echolucency with mortality, independently from 
its thickness (Wohlin et al, 2009). Considering that intima-media selection using 
ultrasound is much quicker and simpler comparing with plaque outline and selection 
and can be done automatically nowadays in newer ultrasound software, intima-media 
GSM could be further investigated as a technique for lipid subintimal deposition 
assessment and as a potential cardiovascular risk marker. 
Looking at the plaque itself, first order grey level parameters were tested for 
association with visual subjective characterization regarding echogenicity and 
homogeneity. Several studies have showed the ability of plaque GSM to objectively 
distinguish echolucent and echogenic plaques and results from this study are similar 
with literature findings. A GSM value of 35 indicated excellent accuracy in 
identifying echolucent plaques, which agrees with previously published GSM 
thresholds. Moreover, plaque variance was significantly lower in echolucent plaques 
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and showed good accuracy in distinguishing echolucent from echogenic plaques. It is 
noteworthy that an association, however not statistically significant, was found 
between plaque size and echogenicity, showing lower GSM in larger plaques. This 
could be mean that plaques with lower echogenicity tend to increase in size and result 
in more severe stenosis or that the plaque echogenicity characteristics change as it 
grows. The latter explanation agrees with recent studies which suggest association of 
plaque shear stress, which is depended on plaque size and morphology, with plaque 
development and composition (Cheng et al, 2006; Li et al, 2008). A study that would 
follow up patients with mild stenosis and compare plaque ultrasound characteristics as 
the disease progresses would provide more details about this association.  
As far as homogeneity is concerned, grey scale value standard deviation was found 
higher in plaques visually classified as heterogeneous, however the difference was 
reported marginally insignificant. Nevertheless, a higher pixel grey scale value 
standard deviation can be expected in heterogeneous plaques, since grey scale 
heterogeneity means greater variation of pixel grey scale values, hence greater 
deviation from the mean. If such an association is established in future studies, this 
parameter could be potentially used for objectively commenting on plaque 
homogeneity, which would be useful for assessing risk for symptoms. 
Calculating the percentage of pixels with grey scale value up to or over a threshold 
has been suggested as another way to assess plaque echogenicity in addition to overall 
plaque GSM calculation (Elatrozy et al, 1998a). Percentages of plaque area 
(percentiles) with grey scale value less than a number of thresholds, ranging from 20 
to 40, were calculated and compared between symptomatic and asymptomatic 
plaques. All investigated percentiles were significantly higher in symptomatic 
plaques, but P35 and P40 (percentages of area with grey scale value up to 35 and 40 
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respectively) indicated great accuracy in distinguishing symptomatic patients. 
Considering the ease of the method, which requires just the outline of the plaque from 
the operator, percentile calculation could potentially be used for further 
characterization of the echogenicity of carotid plaque. 
Thin fibrous cap is one of the characteristics of the vulnerable plaque and ongoing 
research investigates methods to assess it. Although ultrasound lacks the imaging 
resolution of magnetic resonance imaging, studies have shown that fibrous cap 
thickness (FCT) can be accurately measured in ultrasound. Plaque fibrous cap was 
found significantly lower in symptomatic patients (Fig 6.12) and a FCT value of 300 
μm could accurately distinguish symptomatic from asymptomatic plaques (area under 
the curve 0.831). Recent studies have concluded in similar findings and have 
confirmed ultrasound measurements with histological analysis, suggesting that a 
vulnerable plaque has a minimum FCT < 200 μm and a FCT at the most 
representative part lower than 500 μm (Redgrave et al, 2008). Despite the fact that 
measurements of such caliber can be very challenging in ultrasound and could suffer 
from interobserver variability, advances in image resolution and ultrasound software 
could allow easier, even automated, and accurate measurement of fibrous cap 
thickness. 
Regarding fibrous cap echogenicity, a correlation was found with plaque echogenicity 
and plaque regularity in morphology, however not statistically significant. As far as 
symptoms are concerned, in theory, a fibrous cap with diffuse calcification, hence 
more echogenic would correlate with more stable and asymptomatic plaque, 
comparing with fibrous cap with only nodules of calcification, a characteristic that has 
been associated with plaque vulnerability. However, no difference was found in 
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fibrous cap echogenicity between symptomatic and asymptomatic patients, but further 
research could shed more light on the subject. 
Correlation of plaque echogenic characteristics with plaque tissue components has 
been established in studies comparing ultrasound images with histological analysis of 
post endarterectomy specimens. However, it appears that other characteristics of the 
vulnerable plaque, like fibrous cap thickness and plaque heterogeneity can also be 
assessed with ultrasound with promising results. Advances in ultrasound will offer the 
possibility of more accurate plaque composition and morphology assessment, 
providing information that would help decide upon disease prognosis and 
management. 
Further studies, comparing ultrasound findings with histological analysis could 
confirm associations and establish methods for ultrasound investigation of vulnerable 
plaque. Furthermore, reproducibility as well as intraobserver and interobserver 
agreement of these methods should be examined, because plaque and fibrous cap 
selection can be very challenging and result in great variation between operators. Last 
but not least, all the grey level analysis is performed in previously normalized images, 
which is also done manually, lurking the danger for variability and irreproducibility. 
In case future ultrasound softwares implement techniques for image texture analysis, 
they should also implement automated normalization method, possibly by storing a 
duplicate image in the default machine‟s settings, additionally to the image using the 
current settings operator has set for optimal visualization. This way the manual 
normalization could be avoided. 
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7.4 Secondary results 
7.4.1 The PSVICD ratio 
Despite the fact that the investigation of velocity parameters was not a primary aim of 
the study, the collected data allowed the statistical analysis of the various measured 
velocity parameters and ratios. Apart from the PSVR and St. Mary‟s ratio, a third 
ratio was calculated by dividing the PSV in internal carotid artery with the PSV in 
distal non diseased internal carotid artery (PSVICA/PSVICD), named PSVICD ratio. The 
principle behind this ratio is the comparison of blood flow velocities at different 
points of the same vessel, where the vessel caliber is similar and the accommodated 
blood volume is the same. Like all ratios, it would be independent of more proximal, 
distal disease or contralateral disease and heart disease, as well as independent of 
external carotid artery disease, which can affect the systolic and diastolic velocity at 
common carotid artery and hence the other two ratios. 
The PSVICD ratio showed good correlation with the degree of stenosis calculated with 
direct measurement methods as well as current velocity criteria. Comparing with 
PSVR and St. Mary‟s ratio using established threshold values, a PSVICD value of 2.0 
showed greater sensitivity comparing to the first and greater specificity than the latter, 
indicating almost excellent accuracy in identifying greater than 70% stenosis. 
Although accuracy was significantly lower in distinguishing mild (<50%) from 
moderate (50-69%) stenosis using value 1.0 as a threshold, sensitivity and specificity 
indices were similar to those of the two currently used ratios. 
The reproducibility and accuracy of the PSVICD ratio remains to be tested in further 
studies, favorably using other angiographic like methods as reference for degree of 
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stenosis estimation. Its accuracy in categorizing stenosis in 10% ranges should also be 
investigated and should it proves accurate enough, it could potentially be used in the 
future in revised velocity criteria as an additional parameter. However it should be 
noted that the recording of flow in distal internal carotid artery is sometimes 
technically difficult due to anatomical reasons, such as high carotid artery bifurcation 
or vessel tortuosity. This is a limitation of this parameter comparing to the other ratios 
which compare proximal internal carotid artery velocities with common carotid artery 
velocities. 
7.4.2 Score system for plaque vulnerability 
Having scanned both symptomatic and asymptomatic plaques and measured several 
plaque characteristics, from haemodynamic effects of stenosis to plaque grey scale 
median and fibrous cap thickness, a combination of a number of characteristics was 
investigated for ability to distinguish potentially symptomatic from asymptomatic 
plaques. Four characteristics were tested and included in a scoring system; percentile 
40, diameter of stenosis (using ECST direct measurement method), fibrous plaque 
thickness and intima-media thickness. Threshold values were set using ROC curves 
and crosstabs analysis for each characteristic and score points were assigned (Table 
6.6). 
Three categories were defined, according to plaque total score; low, increased and 
high risk for stroke. Statistical analysis indicated greater odds ratio and relative risk 
for stroke for increased and high risk category comparing to low risk plaques, 
showing good accuracy for the score system in identifying potentially symptomatic 
plaques. 
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It is noteworthy that the relative risk for each plaque characteristic separately was 
significantly lower compared to score system relative risk, which shows that the 
combination of vulnerability characteristics in a score system might have greater 
diagnostic value in the identification of the vulnerable plaque. 
A limitation of this score system is the inclusion of fibrous cap thickness 
measurement, which can be challenging in many cases, whereas in some plaques 
cannot be visualized at all. However, in the cases where it could be measured, it 
significantly increased the specificity and the accuracy of the score system. 
Also, the particular score system uses percentile 40 rather than other more 
sophisticated image texture analysis parameters. The reason for that is that in this 
study other grey level parameters failed to show significant difference regarding 
patient symptomatology. Should such difference be proved in further studies for other 
image analysis parameters associated with plaque vulnerability, they could be 
introduced in a more complex score system. 
Furthermore, the score system was created retrospectively, looking on patients with 
known clinical status, but was not tested prospectively in patients. Further research 
that would include patient follow up is necessary to assess score system accuracy and 
diagnostic value. Ideally, future ultrasound software will be able to calculate several 
plaque and stenosis parameters and provide a possibility for plaque vulnerability and 
patient risk. 
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7.5 Preliminary immunohistochemistry study for 
identification of ultrasound image characteristics of 
carotid plaque inflammation and neovascularization 
Plaque neovascularization and inflammation are today considered as major factors for 
atherosclerotic plaque vulnerability and ways to assess those using imaging modalities 
are investigated. Magnetic resonance imaging and positron emission tomography have 
shown good results in identification of both factors, while contrast enhanced 
ultrasound has also been tested for assessing predominantly plaque neovascularization 
and secondary plaque inflammation with promising results. Duplex Ultrasound, 
without the use of contrast agents, has not been used to date for assessing 
inflammation and angiogenesis and grayscale characteristics of plaques regarding 
those two factors have not yet been identified. 
In order to define grey scale characteristics of plaque inflammation and 
neovascularization, a study has been designed to compare ultrasound image texture 
analysis with immunohistochemistry analysis of post endarterectomy specimens using 
CD68 and CD31 for inflammation and neovascularization assessment respectively. 
The study protocol and preliminary data are presented below. 
7.5.1 Patient enrolment 
Patients with diagnosed severe carotid atherosclerotic disease who were considered 
for endarterectomy by vascular surgeons at Charing Cross Hospital, Imperial College 
London NHS Trust, were enrolled to the preliminary study and had a carotid duplex 
ultrasound scan prior to decision for optimal treatment. Study inclusion criteria were 
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symptomatic patients (recent TIA or stroke episode) with previously diagnosed severe 
carotid artery stenosis. 
In total 20 patients were scanned and images were taken from one carotid artery of 
each. From those, eight patients underwent carotid endarterectomy (median 15.5 days 
after the ultrasound scan, mean carotid stenosis 67.8 ± 10.1%) and plaque specimens 
were collected and analyzed.  
7.5.2 Examination protocol and image analysis 
A Philips IU 22 ultrasound scanner was used for carotid scanning, with a 5-12 MHz 
linear array probe. Patients were examined lying supine and the carotid artery that was 
known to have severe stenosis was scanned using the anterolateral projection. After 
the identification of the plaque, depth of image, focus, total gain and time gain 
compensation settings were altered to achieve better visualization. 
Applying the standard carotid duplex ultrasound scan protocol, images of common, 
internal and external carotid were taken and velocity tracings were recorded for 
degree of stenosis estimation. Following that, the protocol described in chapter 6.3.2 
was followed and several pictures of the carotid bifurcation and the internal carotid 
artery were then taken in longitudinal and transverse plane in B-mode and Colour 
Doppler mode. 
Images were transferred in in-lab PCs for editing and analysis. Using Adobe 
Photoshop CS5 and Curves function, images were standardized using the method 
described in chapter 6.4.1. Then, using histogram function GSM and grey scale 
standard deviation was calculated for the whole plaque (method described in chapter 
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6.4.3). Mazda software was then used for calculation of grey level parameters 
(Variance, Skewness and Kurtosis) using the method described in chapter 6.4.5. 
7.5.3 Carotid endarterectomy surgery 
For some of the patients participated in the study carotid endarterectomy surgery was 
selected as the optimal treatment. 
The operation usually is performed under general anaesthesia. It involves an incision 
along the anterior border of sternocleidomastoid muscle and lateral retraction of the 
muscle and internal jugular vein for carotid artery exposure. Distal internal carotid 
artery, well after the plaque point, is mobilized and clamped off and a shunt is put to 
maintain cerebral blood flow. If patient is under local anaesthesia, artery can be 
temporarily occluded rather than placing a shunt and adequacy of compensated 
cerebral blood flow can be checked by patient‟s ability to move hands or feet or talk. 
Common carotid artery and distal external carotid artery are also clamped and artery 
is dissected, starting from internal carotid artery and continuing circumferentially. 
Dissection is then continued in proximal external carotid artery and any plaque is 
removed. In the end, vessel wall is closed using sutures or vein patches, and cerebral 
blood flow is restored after clamp removal. 
7.5.4 Specimen immunohistochemistry analysis 
Following patients‟ carotid endarterectomy surgery, plaque specimen was collected 
and analyzed using immunohistochemistry methods at the Histopathology Department 
of Charing Cross Hospital. 
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Tissue embedding and cryosectioning 
Plaque regions were placed within optimised cutting temperature embedding matrix 
upon 3mm thick cork discs and were rapidly frozen using Frostbite (Surgipath) before 
inserting into a bath of 100% isopropanol surrounded by dry ice to snap freeze. 
Using Leica CM1900 UV cryostat (Leica Microsystems) at -25 ± 1 oC for 
cryosectioning, 5μm sections of plaque region were transferred in slides. Slides were 
labeled depending if the section belonged to the top edge, medium or bottom part of 
the plaque. 
Immunohistochemistry analysis 
Immunohistochemistry protocol, based on the Standard Operating Procedures and 
implemented within Charing Cross Hospital Department of Histopathology, was 
followed for the analysis of the plaque specimens. 
Frozen tissue sections were fixed in acetone at room temperature for 10 minutes. 
Standard Avidin-Biotin Complex immunohistochemistry technique was used. This 
method involves three layers of antibodies; the primary antibody is the study maker, 
CD31 for endothelium and CD68 for macrophages. The second is the biotinylated 
secondary antibody. The third layer is a complex of avidin-biotin peroxidase. Avidin 
is a glycoprotein that can be labelled with peroxidase or fluorescein (chromogen) with 
high affinity to biotin. Due to that affinity, the first layer is amplified at the second 
and third layer, increasing the sensitivity of the method 
Chromogen diaminobenzidine SK-4100 (Vector Laboratories) was added for 
antibody/antigen complex visualization. Diaminobenzidine produces a brown 
precipitate which is insoluble in alcohol in the presence of hydrogen peroxide. 
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Five millilitres of distilled water, 2 drops of buffer stock solution, 4 drops of 
diaminobenzidine stock solution and 2 drops hydrogen peroxidase were mixed and 
added to each slide for 5 minutes. Slides were then immersed in running tap water. 
Surgipath Harris‟s haematoxylin followed by 0.3% acid was applied so the cell nuclei 
were stained blue. 
The slides were then subjected to serial 70% and 90% alcohol baths and finally 
completely dehydrated with 99% Industrial Methylated Spirits (IMS). The alcohol 
was removed using xylene and the sections were mounted in Pertex mountant with 50 
x 35 mm glass coverlips on Leica Auto-coverslipper. 
Pictures of the stained slides were taken for further analysis. For each plaque, three to 
four pictures from bottom, mid and top parts were taken. 
CD31-Platelet Endothelial Cell Adhesion Molecule-1 
Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1), also referred as CD31, is 
a transmembrane glycoprotein adhesion molecule with a molecular mass of 130 kD 
which is highly expressed at the lateral borders of vascular endothelial cells and 
weakly expressed on peripheral leukocytes and platelets. Along with vascular 
endothelial cadherin (VE-cadherin) and vascular endothelial growth factor receptor 2 
(VEGF-R2) forms a shear stress responsive complex, activated by acute onset of 
laminar blood flow. CD31 expression has been detected on endothelial cells of 
atherosclerosis-prone aorta and within neovascularisation regions of atherosclerotic 
plaques (Li et al, 2006; Galkina & Ley, 2007). CD31 immunohistochemistry staining 
has been used for identification of vasa vasorum in arterial wall (Burtea et al, 2008). 
In the study, monoclonal mouse anti-human antibody clone JC70A (DAKO, Glostrup, 
Denmark) was used. 
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CD68 
Monoclonal antibodies against CD68 are widely used specific markers for 
macrophage immunotyping (Kunisch et al, 2004; Micklem et al, 1989). CD68 is a 
heavily glycosylated transmembrane protein of 354 amino acids with molecular mass 
of 110 kD, located mainly in lysosomal membranes of human monocytes and tissue 
macrophages (Holness & Simmons, 1993). Antibodies against CD68 have been used 
for identifying macrophages in a variety of human tissues, including the red pulp of 
spleen, the lamina propria of the gut, the lung alveoli and the bone marrow. In the 
study, monoclonal mouse anti-human CD68 antibody clone PG-M1 (DAKO, 
Glostrup, Denmark) was used. 
Immunohistochemistry image analysis 
The images of the immunohistochemistry analysis were edited and processed for 
CD31 and CD68 expression using Image Pro Plus 6.0. 
Images were loaded into the software and were enhanced using contrast enhancement 
function (Fig 7.3) for the best differentiation between marker expressions (dark brown 
due to diaminobenzidine chromogen), cell nuclei (blue spots due to haematoxylin 
staining), plaque calcification (dark blue areas due to haematoxylin staining) and 
matrix (Fig 7.4). 
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Fig 7.3, Original (left) and post enhancement (right) image using Image Pro Plus 
 
Fig 7.4, Immunohistochemistry image of plaque specimen using CD68 antibody and 
haematoxylin staining. Cell nuclei are stained blue (black arrows) and antibody/antigen 
complex is stained dark brown (red arrows) 
Macrophage infiltration quantification 
Six regions of interest (dimension 200x200 pixels) were randomly selected for each 
CD68 slide. Using the Count/Measure function and histogram and eye drop tools, 
areas of marker expression were highlighted and selected for object and area 
measurement (Fig 7.5). Means were calculated from all regions of interest from all 
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slides of each plaque and plaques were classified between low and high marker 
expression. 
 
 
Fig 7.5, Macrophage infiltration quantification method in plaque specimen using CD68 
antibody and immunohistochemistry technique and Image Pro Plus for image enhancement 
and analysis. Left: region of interest (ROI) of 200x200 pixels of the original picture captured 
from the microscope; Middle: contrast and brightness enhanced picture of the same ROI; 
Right: selection and measurement of antibody/antigen complex area at the same ROI  
 
Plaque angiogenesis quantification 
For CD31 slides, microvessels were identified as round holes in the plaque matrix 
with high marker expression in the perimeter (Fig 7.6). The presence and number of 
microvessels identified in each slide was measured and each plaque specimen was 
classified between low and high neovascularisation. 
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Fig 7.6, Microvessel (black arrow) identified in an immunohistochemistry analysis image of 
carotid plaque specimen with use of CD31 antibody 
Calcification quantification 
In both CD31 and CD68 slides, calcified areas at plaque specimens were identified as 
dark purple areas because of haemartoxylin staining (Fig 7.7). Count/measure 
function and histogram tool were used for selection and measurement of these areas 
and plaques were classified for absence or presence of calcification. 
 
Fig 7.7, Calcified areas at a plaque specimen stained with haematoxylin  
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7.5.5 Comparison of histoimmunochemistry analysis 
results with ultrasound image texture analysis 
Inflammation assessment 
Plaques specimens with increased macrophage infiltration were identified with 
immunohistochemistry methods using CD68 antibody as a marker. Two groups were 
formed, for low and high antibody/antigen expression. Grey scale parameters for 
ultrasound images were compared between the two groups and examined for 
significant difference. 
Among the parameters examined, plaque‟s ultrasound image kurtosis was found to be 
greater (mean 0.49 ± 1.03) in patients whose plaque specimen indicated higher CD68 
expression than in patients whose plaques showed lower expression (mean -0.30 ± 
0.28) (Fig 7.8).  
Kurtosis was normally distributed between the two groups (Shapiro-Wilk test p value 
> 0.05) and independent-samples T-test was used for investigation of the significance 
of difference. Test rejected statistical significance of the difference (p value > 0.05). 
Other grey scale parameters showed no difference between plaques with high and low 
macrophage infiltration. 
It is noteworthy that patients whose plaques indicated a higher CD68 expression on 
the immunohistochemistry analysis had slightly higher, though not statistically 
significant, values for White Cell Count and Neutrophile Count. No other difference 
as far as blood test results or medication was traced between the two groups. 
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Fig 7.8, Kurtosis of ultrasound image of plaques showing high and low CD68 expression in 
immunohistochemistry analysis 
Neovascularization 
Plaque specimens were classified in two groups for low or high neovascularization 
using CD31 antibody and immunohistochemistry techniques. Ultrasound image 
analysis grey scale parameters were computed and compared between the two groups. 
Plaques with greater degree of neovascularization were found to be significantly more 
echolucent (mean GSM 50 ± 29.4) comparing to those with low angiogenesis (mean 
GSM 77 ± 2.8, Mann-Whitney test p value < 0.05) (Fig 7.9).  
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Fig 7.9 Boxplot of plaque grey scale median in plaques with high and low 
neovascularization, as they were classified from immunohistochemistry analysis 
Among the other grey level parameters investigated for the two groups, plaque 
variance was found lower (1263 ± 835) and plaque skewness higher (0.699 ± 0.48) for 
plaques with more significant neovascularization plaques with greater 
neovascularization than for plaques with mild angiogenesis (2074 ± 464 and 0.453 ± 
0.1 respectively) (Fig 7.10). However, the differences were reported statistically 
insignificant (Mann-Whitney U test p value > 0.05). 
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Fig 7.10, Boxplots of variance and skewness computed from ultrasound image analysis for 
plaques with high and low angiogenesis as they were classified using immunohistochemistry 
techniques and CD31 antibody 
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No association was found between degree of diameter and area stenosis caused by the 
plaque and degree of plaque neovascularization. Furthermore, no significant 
difference was found regarding blood test results and medication between the two 
groups. 
Calcification 
Plaque calcification was identified in carotid plaque specimens using haematoxylin 
staining. Grey level parameters computed from ultrasound images were compared 
between patients with calcified and non calcified plaques for significance of 
difference. 
Calcified plaques were found to be more echogenic (mean GSM 74.4 ± 2.6) than non 
calcified plaques (mean GSM 32.3 ± 25.6) (Fig 7.11). Mann-Whitney test results 
indicated significance of difference (p value < 0.05). 
ROC curve was calculated for GSM value to investigate the ability to differentiate 
calcified and non calcified plaques. Area under curve was 1.000 (excellent) and GSM 
cut-off value of 65 indicated 100% sensitivity and 100% specificity for identifying 
calcified plaques. 
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Fig 7.11, Boxplot of grey scale median value of ultrasound image of calcified and non 
calcified plaques, as they were classified from immunohistochemistry analysis 
Images of calcified plaques were also found having greater variance and lower 
skewness than those from non calcified plaques (Fig 7.12) but nonparametric tests 
rejected statistical significance of difference. 
No difference was reported for other calculated image parameters. 
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Fig 7.12, Boxplots of variance and skewness of ultrasound image of calcified and non 
calcified plaques, as they were classified from immunohistochemistry analysis. 
Nonparametric tests rejected significance of difference. 
 
189 
 
7.5.6 Conclusions 
Plaque inflammation and neovascularization have both been associated with plaque 
vulnerability in coronary and carotid atherosclerotic plaques and there is ongoing 
research on imaging and quantifying those characteristics for early and accurate 
identification of unstable plaque. The aim of this preliminary study was to investigate 
ultrasound image grey scale characteristics of carotid plaque inflammation and 
neovascularization, by comparing immunohistochemistry analysis of post 
endarterectomy specimens with ultrasound image texture analysis of carotid plaque. 
Despite the limited number of data, some useful conclusions can be drawn regarding 
plaque inflammation and neovascularization grey scale characteristics that could 
potentially lead in further research. 
 Plaque angiogenesis was well associated with plaque echogenicity and plaques with 
greater number of microvessels had a significantly lower plaque grey scale median 
(Fig 7.8). It is noteworthy that both low and high angiogenesis groups had no 
significant difference in cholesterol and triglyceride blood levels or in cholesterol 
treatment, so the assumption that increased angiogenesis contributes in plaque 
echolucency independently of plaque lipid deposition might be solid. The association 
of plaque echolucency with angiogenesis has also been recently suggested by studies 
performing both standard and contrast enhanced carotid ultrasound, in which plaques 
which in standard ultrasound appeared echolucent showed increased enhancement in 
contrast enhanced ultrasound comparing with the echogenic plaques (Staub et al, 
2011). However, histological analysis that would indicate the equality of lipid core 
and hence the independent role of angiogenesis in plaque echolucency remains to be 
done in future studies. 
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Despite the fact that the difference of the other grey level parameters between plaques 
with high and low neovascularization was not found statistically significant in the 
preliminary data analysis, it is noteworthy that plaques with greater 
neovascularization were characterized by lower variance and higher skewness in 
ultrasound. A larger study could establish or reject such associations. 
Regarding the inflammation of carotid plaques, ultrasound image texture analysis 
reported a greater kurtosis in plaques whose histological analysis showed higher 
CD68 expression, hence greater inflammation. Specifically, kurtosis was 
predominantly positive in inflamed plaques and negative in plaques with low degree 
of inflammation. However statistical analysis rejected the statistical significance of 
the difference and research is needed for further investigation. No association was 
reported between degree of inflammation and other grey level parameters. 
Histology studies that examine carotid plaque composition usually require plaque 
decalcification in order to further assess the specimen for lipid core and intraplaque 
haemorrhage quantification. In those studies plaque calcification cannot be accurately 
measured but only estimated from the volume of missing tissue. Cryosectioning 
technique used in this study enabled cut of plaque specimen without preceding 
decalcification, allowing plaque calcification identification and quantification using 
haematoxylin staining. Generalized plaque calcification is considered as a stability 
marker for carotid atherosclerotic plaque, comparing to spotty calcification that has 
showed association with plaque vulnerability. Furthermore, degree of plaque 
calcification plays an important role on selection of revascularization treatment, since 
heavy lesion calcification is considered as a contra-indication for carotid angioplasty 
and stenting. 
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Comparing ultrasound image analysis results with specimen histological analysis for 
calcification assessment, plaque grey scale median was found significantly higher in 
calcified plaques. Using a value of 65 as a threshold, this technique showed excellent 
sensitivity and specificity in distinguishing calcified from non-calcified plaques. 
Should this method be evaluated in larger studies, this easily acquired parameter 
could be used to decide upon plaque calcification deposition of atherosclerotic plaque. 
The preliminary data analysis also indicated an association between calcified plaques 
and lower skewness and greater variance of ultrasound images; however the 
association was not statistically significant. A larger study could provide the 
necessary data for confirmation or rejection of such an association. 
7.6 Future research recommendations 
Over the last decades there has been considerable evolution in ultrasound technology 
and great amount of research on the potential of ultrasound in providing more 
accurate stenosis assessment as well as qualitative and quantitative details about 
carotid plaque. However, clinical evidence suggests that carotid atherosclerotic 
disease approach with ultrasound has not significantly changed, failing to incorporate 
modern research results. 
The haemodynamic effect of stenosis is valuable clinical information and current 
ultrasound investigation is predominantly based on this by estimating degree of 
stenosis through velocity parameters. However, there are cases where detailed 
measurements regarding the size of plaque in longitudinal and transverse views as 
well as the exact stenosis measured directly in B-mode and Colour Doppler images 
could more accurately describe the extent of the disease, alongside haemodynamic 
information. This study has indicated that ECST method of direct measurement when 
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applied in ultrasound could potentially be an accurate alternative method for stenosis 
measurement, showing good correlation with velocity criteria and MRA 
measurements. Larger studies, that would enroll a greater number of patients and 
assess the stenosis with more imaging modalities, such as digital subtractive 
angiography and three-dimensional ultrasound, could allow a better evaluation of 
direct measurement approach for deciding upon its inclusion in the standard carotid 
ultrasound imaging protocol. 
Regarding plaque composition, numerous studies have shown correlation of grey 
level analysis results with particular tissue components, whereas modern research has 
looked on the use of second order statistics for plaque characterization and changes 
monitoring related to treatment. Further research is needed for confirming these 
results and incorporating them in ultrasound software, in a way that future ultrasound 
machines can offer plaque mapping with compositional details. 
This study‟s results suggest potential association of grey level statistics with 
inflammation and neovascularization. However, the small number of patients prevents 
any solid conclusions. Future studies which would enroll greater number of patients, 
apply more sophisticated image texture analysis and use immunohistochemistry 
analysis for plaque inflammation and neovascularization assessment of post-
endarterectomy specimens are required for establishment or rejection of the 
association. In case of confirmation of such association, incorporation of this texture 
analysis in ultrasound software would allow even better identification of vulnerable 
plaque. 
Modern research has also focused on fibrous cap assessment for plaque risk of rupture 
stratification. This study‟s results indicate a strong association of fibrous cap 
thickness measured in ultrasound and symptomatic disease, which has been suggested 
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by histological studies. However, the reproducibility of the method was not assessed, 
while the number of plaques that allowed measurement of fibrous cap thickness was 
limited. A small number of published studies recommend methods for ultrasound 
assessment of fibrous cap, however there are doubts about the accuracy of 
measurement due to technical limitations (Devuyst et al, 2005). Evolution of 
ultrasound technology and improvement of image resolution could allow accurate 
identification and measurement of fibrous cap and further research is recommended 
for establishment and evaluation of methods to assess it. Moreover, analysis of the 
grey level of fibrous cap could potentially be another way to assess plaque 
vulnerability and more studies are required to elucidate this aspect. 
Intima-media thickness has long been considered a useful marker of atherosclerosis in 
the arterial network and is routinely monitored for disease progression and treatment 
evaluation. Only recently have researchers investigated the association of its 
echogenicity with symptomatic disease and plaque characteristics (Wohlin et al, 
2009; Lind et al, 2007). This study‟s results agree with recently published data, 
suggesting an association of intima-media grey level with carotid plaque grey level, 
though not statistically confirmed, as well as a strong correlation of intima-media 
echolucency with patient‟s blood cholesterol levels. Further studies that would look 
into more in-depth intima-media image texture analysis and investigate association 
with more cardiovascular risk factors, carotid plaque characteristics, clinical 
symptoms and disease progress could provide useful information for intima-media 
assessment and disease management. 
The preliminary immunohistochemistry study‟s results suggest potential association 
of grey level statistics with inflammation and neovascularization. However, the small 
number of patients prevents any solid conclusions. Future studies which would enroll 
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greater number of patients, apply more sophisticated image texture analysis and use 
immunohistochemistry analysis for plaque inflammation and neovascularization 
assessment of post-endarterectomy specimens are required for establishment or 
rejection of the association. It is suggested that additional markers for 
neovascularization assessment, such as CD34 and VEGF antibodies, could make the 
analysis easier and more accurate in future studies. Furthermore, a future study could 
look into histology analysis of the same specimens regarding both compositional 
tissues and inflammation and angiogenesis, so as the contribution of each plaque 
characteristic in ultrasound image texture could be independently investigated. In case 
of confirmation of association between ultrasound image characteristics and plaque 
inflammation, neovascularization and calcification, incorporation of texture analysis 
in ultrasound software would allow even better identification of vulnerable plaque. 
Apart from duplex ultrasound, there is ongoing research on methods of carotid plaque 
assessment using contrast enhanced ultrasound. Numerous studies have shown 
promising results regarding identification of plaque neovascularization, whereas only 
a few have looked into the assessment of plaque inflammation using late-phase 
contrast enhanced ultrasound (Feinstein, 2006; Owen et al, 2010). More research is 
needed for standardization of methods and evaluation of their accuracy, while 
methods for computerized quantification of plaque contrast enhancement need to be 
established. 
Scientific interest has also been turned towards three-dimensional ultrasound, which 
has been simplified by the development of 3D ultrasound probes and modern image-
analysis software and offers the advantage of volumetric vascular imaging. Recent 
studies have concluded on very high reproducibility in plaque volume measurement 
and good reproducibility in plaque morphology and composition assessment. 
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However, it should be noted that 3D ultrasound can be more technically challenging 
comparing with 2D ultrasound (Makris et al, 2011). Furthermore, three-dimensional 
ultrasound may allow a simplified assessment of wall shear stress, which appears to 
be of great importance in the progress of atherosclerotic disease. More research is 
needed for method establishment and accuracy evaluation of this new promising 
modality. 
7.7 Summary 
Duplex ultrasound stands today as the main imaging modality for assessing carotid 
atherosclerotic disease. Despite research results on new methods and techniques for 
ultrasound investigation of carotid plaque, carotid stenosis assessment in clinical 
practice is still based on velocity criteria, providing information about the 
haemodynamic effects of the stenosis and indirectly estimating its degree. To date, 
direct stenosis measurement or quantitative characterization of plaque have not been 
included in the standard investigation protocol. Meanwhile, other imaging modalities 
like computed tomography angiography and magnetic resonance angiography have 
enabled assessment of parameters beyond that of luminal stenosis. 
Summarizing the study results, regarding direct stenosis measurement, ECST method 
superiority among the direct methods for carotid stenosis measurement is apparent 
and its inclusion in carotid ultrasound investigation protocol could improve the 
estimation of degree of stenosis, especially in cases where velocity criteria give 
inconclusive results or seem inconsistent with visualized stenosis. Furthermore, grey 
scale texture analysis of plaque ultrasound image appears able to provide information 
about plaque heterogeneity and vulnerability, since some parameters show good 
correlation with lipid and calcification deposition and are related with increased risk 
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for stroke. Regarding plaque neovascularization and inflammation, association with 
grey scale parameters seems promising, however it remains to be proved in future 
studies. Plaque fibrous cap thickness measurement and intima-media grey scale 
analysis could also provide information about potentially symptomatic plaque that 
could help identify high risk patient. 
Research on atherosclerosis constantly updates plaque formation mechanisms adding 
new factors related to plaque growth and risk of rupture. Taking into consideration 
current knowledge around carotid atherosclerotic disease, current carotid plaque 
ultrasound assessment that looks only on the degree of stenosis using velocity 
parameters seems obsolete. A lot of ultrasound potentials remain unexploited and 
duplex ultrasound may be held back by the excuse of inaccuracy. A revised holistic 
ultrasound approach of carotid plaque, which will combine accurate stenosis 
measurement using uniformly accepted methods, stenosis haemodynamic effect with 
velocity parameters as well as quantitative details about plaque morphology, 
composition, inflammation and neovascularization could increase duplex ultrasound 
efficacy in the investigation of carotid atherosclerotic disease, making it a powerful 
diagnostic tool for patient screening, assessment and following up. 
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